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ABSTRACT
Vitrification is the latest technique used in cryopreservation, the ability to utilize this
method with oocytes and embryos has become a valuable system. Vitrification has been
successful with bovine embryos and oocytes but is far from optimal. Following
cryopreservation storage discarding embryos can cause ethical issues, and mature oocytes
have fragile organelles that can be detrimentally affected by ice crystal formation during
freezing. Immature oocytes have not formed some of these temperature sensitive
microfilaments and can circumvent these detrimental effects. The common intracellular
cryoprotective agents are dimethyl sulfoxide, glycerol and ethylene glycol. Different
combination of these agents have been reported for vitrification of oocytes.
The overall objective of this experiment was to determine if immature and mature
cumulus cell complexes vitrified in solutions of dimethyl sulfoxide or glycerol in combination
with ethylene glycol would be competent to produce pronuclei following thawing and in vitro
fertilization. Two experiments evaluated two cryoprotectant solutions and their ability to
fertilize bovine cumulus cell complexed oocytes (n=400). The first study used DMSO and
glycerol containing vitrification solution with immature bovine oocytes (n=200) followed by
IVM and IVF with an end point of pronuclei formation to indicate fertilization. The second used
DMSO and glycerol containing vitrification solutions with mature bovine oocytes (n=200)
followed by IVF. We found that vitrifying immature oocytes with DMSO or Glycerol containing
solutions prior to IVF resulted in higher fertilization for DMSO P<.01. Vitrifying mature oocytes
with DMSO or glycerol containing also resulted in higher fertilization for DMSO solution P<.05.
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These results suggest that DMSO may be the more appropriate choice when used in
combination with ethylene glycol for vitrification of immature and mature oocytes.

x

CHAPTER I
INTRODUCTION

In vitro embryo production (IVP) including in vitro maturation (IVM), in vitro
fertilization (IVF) and in vitro culture (IVC) is an invaluable tool for human fertility clinics as
these assisted reproductive technologies help to provide infertile men and women with
children of their own (Hansen, 2013). IVP is also a valuable tool for commercial livestock
production due to the fact that it increases the number of offspring that can be produced from
each animal per year (Hansen, 2013). Through the use of transvaginal ultrasound guided
oocyte pickup, it is possible to retrieve many oocytes per cow on a weekly basis. These oocytes
can then be matured and fertilized in vitro before transfer into recipient cattle to produce
many viable embryos and offspring (Hiroyoshi, 2002). This is especially useful for maximizing
the offspring potential of genetically valuable animals.
In vitro production can be further maximized through use of cryopreservation for long
term oocyte storage (Shaw and Troson, 2000). However, cryopreservation of embryos can be
costly, hard to manage, and at times may pose moral and ethical issues. Cryopreserving
mature oocytes can result in damage to the metaphase spindle due to the temperature
sensitivity of microfilaments and microtubules as well as other morphological issues (Baka et
al, 1995). Cryopreservation of immature oocytes may circumvent this problem because these
structures have not yet formed and the genetic material is enclosed within a nuclear envelope
(Benson, 2008). Cryoprotectants, such as dimethyl sulfoxide and glycerol, help to prevent ice
crystal damage during cryopreservation (Fuller, 2004). There has been discussion on which
cryoprotectant and concentration works better for certain cell types and sizes. Recent studies
1

have also shown that a newer technique, termed vitrification, results in a significant
improvement over the traditional slow-rate freezing procedure (Lawson, 2011). These results
vary with cell type, cell size and species used in vitrification, a fast freezing technique that
transforms a liquid into a glass like structure. It has also been shown that intact cumulusoocyte complexes (COC) are essential for normal maturation and should be intact during the
vivo or vitro maturation and fertilization periods (Senger, 2005).
The overall goal of this research is to determine if immature and mature COC’s
cryopreserved via vitrification with dimethyl sulfoxide (DMSO) or glycerol will form pronuclei
following thawing and in vitro fertilization, indicating viability. This study will compare DMSO
and glycerol cryoprotectants within each oocyte group. Survival rates will be compared to
determine if it is possible to vitrify immature oocytes as an alternative to mature oocytes for
future cryopreservation procedures. This will help to determine which cryoprotectant has a
higher survival rate with bovine oocytes, immature or mature and determine whether one
cryoprotectant treatment may be optimal for a particular oocyte stage and identify whether or
not these oocytes can become viable embryos.
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CHAPTER II
LITERATURE REVIEW

HISTORY
Gamete cryopreservation was initially established primarily for use in male infertility
treatments, but has since expanded to become an important tool in many aspects of assisted
reproduction (Bunge, 1954). Fowl spermatozoa were first cryopreserved in 1949 using glycerol,
thus making them the first mammalian reproductive cells to be successfully frozen, (Polge and
Parks, 1949) and remain the easiest gamete to freeze today. The development of techniques
for cryopreservation of human spermatozoa for use in human reproduction is credited to
Sherman and Bunge’s work in the mid 1950’s (Bunge and Sherman, 1954). The use of glycerol
was further studied in the 1950’s to attempt cryopreservation of unfertilized mouse oocytes
(Sherman, 1959) and rabbit zygotes (Smith, 1953) but with minimal success. Cryopreservation
of oocytes and their ability to become viable embryos proved more challenging than
cryopreservation of the spermatozoa cells, mainly because many procedures caused damage
to the zona pellucida (Shaw, 2000, Baka, 1995, Magistrini and Szollosi, 1980). Another problem
was thought to be due to the meiotic spindles sensitivity to cold temperatures, causing
irregularities in meiosis (Shaw, 2000 and Baka, 1995). This was demonstrated in mouse
oocytes where upon return to 37°C, the spindle would reorganize in an abnormal shape with
the chromatids scattered throughout the ooplasm (Pickering, 1987). This was believed to be a
possible cause for increased aneuploidy in cryopreserved oocytes (Pickering, 1987). In the
1980’s cryopreservation protocols for embryos and spermatozoa success was established
resulting in live mice births (Pickering, 1987). Other studies at the time raised concerns about
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fertilization of cryopreserved mature oocytes after observations of physical damage (Todorow,
1989) and structural modifications to the zona pellucida (Todorow, 1989). These studies
established the necessity for a slow cooling cryopreservation protocol for oocytes and
cleavage-stage embryos. Successful cryopreservation of spermatozoa and embryos has made
assisted reproductive technologies (ART) more practical and available for commercial use
(Baldassarre and Karatzas, 2004). The advantages of cryopreservation being the ability to
transport gametes long distances, to remove the requirement of estrous synchronization and
therefore reduce the number of recipients required (Do and Taylor-Robinson, 2014). There are
now a range of cryopreservation protocols that can be used to preserve both mature and
immature oocytes, embryos and spermatozoa.
OOGENESIS
In mammals, oogenesis (the development of an oocyte) begins early in fetal
development and ends months to years later in the sexually mature female, puberty.
Oogenesis begins with primordial germ cell formation (Senger, 2005). Once established they
are then referred to as oogonia and will eventually undergo a final round of DNA replication
before entering meiosis and becoming oocytes. After puberty oocytes will enter meiotic
prophase one before arresting at the diplotene phase. This arrest is maintained until the
dominant follicle is stimulated by a gonadotropin surge (Senger, 2005). Oocytes must grow in
follicles to become competent to resume nuclear maturation and undergo fertilization and
cleavage divisions. When oocyte growth is complete they are capable of progressing through
germinal vesicle breakdown and resume meiosis. During the oocytes growth phase, the
oocytes undergo a complex reorganization of organelles within the cytoplasm. Replication of
4

the cytoplasmic organelles during oogenesis, specifically the mitochondria and mitochondrial
DNA, is crucial as the cytoplasmic inheritance of the zygote originates in the oocyte (Alberts,
2002). During oocyte growth phase, the mitochondria rapidly multiply, and organelles become
less active. Within the maturing oocytes ribosome numbers increase and organelles move
towards the cell periphery (Senger, 2005). As the oocyte continues to grow an increasing
number of pores appear in the nuclear membrane around the nucleolus, indicating the
beginning of maturity (Alberts, 2002). At the end of the growth period and just before meiotic
maturation, the oocyte nucleus is large, pale, and immature, referred to as a ‘germinal vesicle’
(GV) (Senger, 2005). Once the dominant follicle is stimulated the primary oocyte starts to
develop into an ootid, through resumption of meiosis. This stage occurs after puberty and
development continues to a secondary oocyte with extrusion of the first polar body, these
oocytes are now considered mature and are ready for ovulation and fertilization (Senger,
2005).
Surrounding both immature and mature oocytes are layers of cumulus cells. These cells
develop from specialized granulosa cells that differentiate into mural granulosa cells and
cumulus cells during follicular antrum formation. Cumulus cells are biologically different from
other follicular cells and execute specific roles including, transmitting signals within the ovary
and supporting oocyte growth and maturation during the later stages of follicular
development (Senger, 2005). They surround and nourish the oocyte. The communication
between cumulus cells and oocytes is bidirectional and imperative for regulating both oocyte
and cumulus cell development. Oocytes have fewer energy sources than necessary for proper
oocyte growth so the cumulus cells are needed to transfer energy to the oocyte through gap
5

junctions (Franciosi et al., 2014). After the luteinizing hormone surge, granulosa cells produce
epidermal growth factors that act on cumulus cells to induce cumulus expansion and oocyte
maturation (Hung et. al, 2015). Cumulus cells regulate oocyte growth, oocyte maturation and
the fertilization process (Da Costa et. al, 2015). A high proportion of fertilized oocytes express
an abnormal fertilization rate following maturation when there is an absence of cumulus cells
around the oocyte. Matured oocytes with intact cumulus cells before fertilization were able to
develop to viable fetuses at similar rates to ovulated oocytes after in vitro fertilization
(Vanderhyden and Armstrong, 1989). This demonstrates the essential role for cumulus cells in
assisting normal cytoplasmic maturation of oocytes necessary for pronuclear formation and
complete developmental capacity (Vanderhyden and Armstrong, 1989). In another study
completed by Jin and associates, it was concluded that the maintenance of cumulus cells can
improve the developmental ability of vitrified thawed mature human oocytes resulting in
successful pregnancy. In comparison, oocytes with the cumulus cells removed prior to
cryopreservation had a significantly lower fertilization rate (Jin et. al, 2012). An additional
study by Purohit found that immature cumulus enclosed compact goat oocytes better tolerate
cryopreservation stress, as assessed by fertilization rates when compared to immature,
denuded and in vitro matured oocytes (Purohit et. al, 2012). In conclusion cumulus cells are
needed on oocytes regardless of maturity, especially with in vitro maturation of the oocytes.
COLLECTION
While there are different methods for the recovery of oocytes, aspirating follicles from
ovaries of slaughtered animals is currently the most common procedure. However, due to its
terminal nature, this technique cannot be repeated on any single animal (Hashimoto et. al,
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1999). To continually repeat collection of bovine oocytes from naturally cycling cows, the
transvaginal ultrasound guided follicular aspiration technique (TUGA) was developed (Pieterse
et. al, 1988). With TUGA, an epidural anesthetic is normally given to prevent abdominal
straining and to ease palpation. The standing cow is restrained so that little movement is
possible during oocyte collection (Manik and Palta, 2003). After retraction of the uterus the
right or left ovary is placed against the head of the transducer which had been inserted into
the vagina adjacent to the cervix. The antral follicles appear as black round spots on the
monitor of the scanner and the puncture needle is depicted by a hyperechoic line going into
the ovary (Manik and Palta, 2003). The transducer is positioned so that the puncture line on
the monitor transects the follicle to be punctured. When a follicle is positioned steadily on the
puncture line, the needle will be pushed through the vaginal wall until its tip becomes visible
within the follicle (Pieterse et. al, 1991). This is directly followed by aspiration of the follicular
contents. After the needle is withdrawn from the ovary and the transducer from the vagina,
the needle is flushed with phosphate-buffered saline solution (PBS). The fluid of each follicle is
collected in a filter and inspected for the presence of an oocyte (Pieterse et. al, 1991).
CRYOPRESERVATION
Cryopreservation of oocytes enables scientists to store oocytes long term from patients
that are in danger of losing ovarian function, while relieving many of the ethical concerns
associated with embryo cryopreservation (Shaw and Troson, 2000, Baka et. al, 1995). The first
challenge in cryopreserving cells from warm-blooded animals is in cooling the cells below body
temperature. Cells may incur damage, referred to as chilling injury, from the low temperatures
(Baka et.al, 1995). Cryopreservation is the use of very low temperatures to preserve intact
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living cells and tissues at approximately -196°C. At these low temperatures, all biological
activity stops, including the biochemical reactions that lead to cell death and DNA degradation
(Shaw and Troson, 2000). Water is the major component of all living cells and must be
available for the processes of life to occur, cellular metabolism stops when water in the
structure is converted to ice crystals. The behavior and function of membrane lipids and
proteins may be affected during the freezing process as well (Shaw and Troson, 2000).
Cryopreservation relies on the ability of small molecules to enter the cell’s cytoplasm and
prevent both dehydration and formation of ice crystals within the cell. Ice crystals form at
different times during the freezing process. At temperatures at or below 0°C, water resists the
breaking of hydrogen bonds and the molecules lock together, this creates pockets of open
space between tight parts of the structure where ice crystals may form (Pickering, 1987). Ice
crystals have the capacity to grow into complex clusters forming networks that can grow
exponentially as more and more water molecules interact to form increasingly complex
crystals. Ice nucleation affects the structural, osmotic, and colligative integrity of cells causing
physical ruptures and mechanical injury (Benson, 2008). With the help of cryoprotectants ice
does not begin to form until about -5°C. Extracellular water begins to freeze between -5 and 15°C but the cell contents remain unfrozen and super cooled. The plasma membrane blocks
the growth of any ice crystals into the cytoplasm (Albrecht, 1982) and the water within the cell
has a higher chemical potential than the water that is partially frozen outside of the cell,
therefore the water flows out of the cells to freeze extracellularly (Albrecht, 1982). The actual
physical events within the cell depend on the cooling speed (Alink and Offerigns, 1977). When
cooling the cell slowly, the cell is able to lose water by exosmosis. The cell will then dehydrate
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and intracellular freezing will be avoided. During rapid cooling, the cell is not able to lose water
fast enough to maintain the equilibrium between the external and intercellular membranes, it
becomes increasingly super cooled and will eventually reach equilibrium by the intracellular
freezing as a glass like substance (Alink and Offerigns, 1977).
Scientists are challenged with stabilizing replicable genetic material to preserve it
unchanged. The aim of cryopreservation is to enable cells to be stored and to prevent the
need to have all cell lines in culture at all times. This is invaluable when dealing with cells of
limited life span. Other main advantages of cryopreservation are the reduced risk of microbial
contamination, the reduced risk of cross contamination with other cell lines, the reduced risk
of genetic drift and morphological changes, and the reduced costs (Sigma,2010).
Cryopreservation also plays an important role in assisted reproduction, it enables the
reproductive cells collected and/or fertilized in one treatment cycle, to be used for fertilization
and/or implantation into the uterus in a future treatment cycle.
CRYOPROTECTANTS
Cryoprotectants (CPA) is the functionally derived term created to describe any additive
which can be provided to cells before freezing to yield a higher post thaw survival than can be
obtained in its absence. The first recorded example of deliberately adding a cryoprotectant,
was the works of Polge and colleagues (Polge and Parks, 1949). They established factors for
success of cryoprotectant activity of a particular solute, the addition of glycerol (Polge and
Parks, 1949). In order for the cells to survive the cryopreservation process, they must maintain
intact organelle membranes and have no intracellular ice crystal formation (Agca et. al, 1998).
Cryoprotectants guard the cell during freezing, are nontoxic in low concentrations and are
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inexpensive (Felipe de Lara Janz et. al, 2012). Cryoprotectants also help to ensure high levels of
cell viability post thaw, and lower freezing temperatures allowing for greater dehydration of
cells before water freezes (Watson, 1995). Cryoprotectants act not only as an osmotic gradient
to aid in the water movement across the membrane, but also as antifreeze, to reduce the
temperature at which ice crystals form. Cryoprotectants are separated into two main classes
intracellular agents, and extracellular agents. Intracellular agents include ethylene glycol,
dimethyl sulfoxide, and glycerol, these penetrate inside the cell preventing the formation of
intracellular ice crystals that could result in membrane rupture or destruction. Intracellular
cryoprotectants have low molecular weight and amphipathic properties, permeate cells and
are effective in minimizing cell damage in many slow frozen biological systems (Agca et. al,
1998). These are the most commonly used cryoprotectants, with glycerol being the most
widely used. Glycerol is a small trihydroxy sugar alcohol, poly-hydroxylated solute with high
solubility in water, and low toxicity to living cells with short exposure periods. It can interact by
hydrogen bonding with water, and can permeate across the plasma membrane of many
different cell types (Agca et. al, 1998). Cells may tolerate exposure to glycerol in
concentrations between 1 to 5 mol/L, depending upon cell type and conditions of exposure
(Fuller, 2004). There are many debates about which intracellular cryoprotectant to use when
freezing as dimethyl sulfoxide, glycerol and ethylene glycol are comparable to one another in
many respects. In recent studies dimethyl sulfoxide has been used more often for oocytes and
embryos (Schellander et. al, 1994). In one particular study dimethyl sulfoxide treatment led to
significantly better cleavage and development up to 4-cell stage in oocytes cryopreserved at
the MII stage. However, development beyond the 8-cell stage was obtained only when
10

immature oocytes were frozen (Schellander et. al, 1994). It was found that when using glycerol
and 1,2- propanediol in vitrification of bovine blastocysts the success following the 16 step
equilibration minimized the ultrastructural damage to the plasma membrane during freezing
and therefore ice crystal formation (Kuwayama and Nagai, 1994). In another study it was
noted that when vitrifying immature and mature equine and bovine oocytes in ethylene glycol
that the maturation rates after vitrification were higher in bovine oocytes than equine at 70%
and 30%, respectively (Hurtt et. al, 2000). Depending on the source consulted, there have been
variable results on the relative toxicity of the different cryoprotectants, with disagreement on
which is the least toxic (Lawson and Sambanis, 2011, Huang et. al, 2006, Aye et. al, 2010,
Comizzoli and Pukazhenthi, 2004). Many factors for optimizing cryopreservation are
dependent on the cell type and species including cryoprotectants used, experimental protocols
and thawing time.
The second class of cryoprotectants are extracellular cryoprotective agents, such as
sucrose, trehalose, or dextrose. These do not penetrate the cell membrane and act to improve
the osmotic imbalance that occurs during cryopreservation. Extracellular CPA’s can also be
used entirely on their own, to increase the osmolarity of extracellular solution, to help draw
water out of the cells. Osmotic imbalance occurs within the cell when water is removed from
the extracellular environment and the water going through the cell membrane is moved out of
the cell. When the extracellular solute concentration is too high and water moves out of the
cells rapidly, it can be harmful. If too much water is inside the cell during cryopreservation, ice
crystals will form and recrystallization during thawing can occur and lyse the cell. Felipe de
Lara Janz stated that when cells were preserved in sucrose and trehalose alone they had a low
11

rate of stem cell viability and therefore had an increase in lag phase after thawing (Felipe de
Lara Janz et. al, 2012). These problems occurred due to the fact that extracellular agents alone
do not adequately prevent the formation of ice crystals within the cell. The combination of

Table 2.1 Factors Associated with Cooling and Cryopreservation that Contribute to Cellular
Injury and Death in Biological Systems (Adapted from Shaw and Troson 2000)
System

Type/cause of damage

All

Intracellular ice formations, extracellular ice formation, apoptosis,
toxicity, calcium imbalance, free radical, ATP levels, general
metabolism, fertilization failure, cleavage failure, pHi,
parthenogenetic activation,

Membrane

Rupture, leakage, fusion, microvilli, phase transition

Chromosomes

Loss/gain, polyspermy, polygyny (failure to extrude polar body),
tertrapliody

DNA

Apoptosis, fusion, rearrangements

Cytoskeleton

Microtubules dissolve, actin

Proteins/enzymes

Dehydration, loss of function

Ultrastructure

Microvilli mitochondria, vesicles, cortical granules, zona pellucida

Zona Pellucida

Hardening, fracture

Lipids

Free radical?

both cryoprotectant agents can optimally preserve cells but there are many factors that need
to be evaluated for each individual experiment before creating a protocol. The concentration
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of cryoprotectants, the combination of cryoprotectants, length of exposure time to each
solution, and other factors affect the viability of the cells being cryopreserved. Table 2.1 shows
the type and cause of damage during cryopreservation within the biological system (Shaw and
Troson, 2000).
High concentrations of cryoprotective agents can be damaging to cells (Meryman,
1971). In general, vitrification requires a two to three step procedure of moving cells through
increasing concentrations of cryoprotective agents to minimize osmotic shock (Meryman,
1971). The first solution consists of low concentration to remove the majority of the water
from the cell often referred to as an equilibrating solution. The second and third solutions
consist of higher concentrations with the cells only exposed for a brief time to minimize the
risk of toxicity. A study showed that reducing the amount of time of exposure to vitrification
solutions can reduce the risk of toxicity to the cell (Ishimori et. al, 1993). Another study
completed by Yamada and colleagues compared the efficiency of vitrifying immature oocytes
in different combinations of ethylene glycol, glycerol and dimethyl sulfoxide at various time
intervals. In the first experiment, oocytes were exposed to the cryoprotectant for either 30 or
60 seconds in final solutions of 20 % ethylene glycol + 20% dimethyl sulfoxide or 25% ethylene
glycol +25% dimethyl sulfoxide. In the second experiment, the oocytes were vitrified in open
pulled straws (OPS) using a 30 second exposure to final solutions as above. The post-thaw
maturation rates showed that a 30 second exposure did not differ from the control groups but
that a 60 second cryoprotectant exposures was toxic to the cells, reducing the maturation
rates. The second solution of 25% ethylene glycol + 25% dimethyl sulfoxide enhanced the
maturation rates compared to the other solutions used. The concentration of cryoprotectants
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used in this study showed their importance on the post thaw development and survival rate of
vitrified oocytes (Yamada et. al, 2007). Si and colleagues found that glycerol at concentrations
below 5% in comparison to 15% dimethyl sulfoxide led to improved post-thaw survival (Si et.
al, 2004). In addition to all these different factors the cooling rate has been proven to have a
significant impact on long term cell viability (Fasano, 2014). Not only does cooling rate affect
the rate of formation and size of both intracellular and extracellular ice crystals; it can also
impact solution effects that occur during the freezing process (Fasano and Vannin, 2014).
There are two main freezing procedures that are used today; slow rate cryopreservation and a
fast freezing method termed vitrification.
SLOW RATE CRYOPRESERVATION
Most oocyte and embryo cryopreservation systems use a controlled rate freezer for a
process known as slow rate cooling or conventional cryopreservation. This freezing system
leads to the extracellular solution freezing before intracellular ice crystals form creating an
osmotic imbalance across the cell membrane leading to the water leaving the cell. Liquid
nitrogen is poured into a closed chamber system that is connected to a computer system,
controlling the rate at which the internal chamber, where cells are placed, is cooled. During
this process there was an increase in the solute concentration outside and inside the cell due
to ice crystal formation, this can be detrimental to cell survival (Mavrides and Morroll, 2002).
The freezing rate is set to optimize cell dehydration and so prevent intracellular ice crystal
formation. The embryos or gametes are placed into a programmable freezer that can be set
and reduced to any temperature. One common protocol starts at 23°C and reduced -2°C per
minute to -8°C then seeded and held for 5 minutes. The system then reduces -0.3°C per
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minute to -30°C, -50°C per minute to -140°C and held for 15 minutes. This can take anywhere
from an hour to three hours, depending on the set cooling rate, but allows many cells to be
frozen at the same time (Mavrides and Morroll, 2002). The frozen suspension is then
transferred to a liquid nitrogen tank and maintained at subzero temperatures for
indeterminate lengths of time. The consequences of this slow and gradual freezing process
have been documented to include cellular injury, resulting in cell death, especially from -15°C
to -30°C (Djuwantono et. al, 2011). Cells pass through this critical range twice; during freezing
and again during thawing. The transition of the cells from fluid to solid state could also cause
osmotic injury. In recent literature, the survival of cryopreserved human oocytes following
slow rate freezing ranged from 74% to 90%(Chen and Yang, 2009). About 85% of slow rate
frozen matured oocytes had normal morphological characteristics in another study (Sinha
et.al, 2014). Bianchi questioned if the cryopreservation machine may be obsolete in a study
performed in 2012 (Bianchi et.al, 2012) concluded that in infertile human couples undergoing
in vitro fertilization treatments he found that slow freezing of oocytes can be a valid tool still in
practices with in vitro fertilization when using suitable protocols (Bianchi et. al, 2012). A study
aimed to evaluate the ability of slow freezing for cryopreservation of immature, germinal
vesicle porcine oocytes found that slow freezing is a feasible approach for cryopreservation of
porcine germinal vesicle oocytes when the correct cooling rate is used. The results indicated
that the cooling rates of 6, 3 and 1.5°C per minute could be considered as possible
cryopreservation protocols when using 2.0M DMSO (Yang et. al, 2012). This study also verified
an effective approach for optimal cooling rates by evaluating the intracellular ice crystal
formation characteristics of porcine germinal vesicle cumulus cell complexed oocytes (Yang et.
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al, 2012). Literature reviews have shown that the majority of pregnancies to date have been
accomplished with a slow freezing protocol (Oktay and Bang, 2006). Both slow rate freezing
and vitrification methods for oocyte cryopreservation can be used effectively with subsequent
successful pregnancies (Oktay and Bang, 2006). However, recent improvements in the
vitrification technology have enhanced its effectiveness and because of its simplicity made it
the method of choice in oocyte cryopreservation.
VITRIFICATION
Vitrification is a fast freezing technique, that transforms liquid into a glass like state
without ice crystal formation. It was developed in 1985 and requires no expensive
programmable freezing equipment (Rall, 1985) unlike the slow-freezing process. It relies on an
extremely high concentration of CPAs to create highly viscous solutions in which ice crystals
cannot form, rather than relying directly on cell dehydration (Rall, 1985). Rall first showed that
a murine embryo could be successfully cryopreserved, but the vitrification solution they used
was highly toxic (Rall, 1985). Later studies by Rall were successful with live mice born following
embryo vitrification (Rall, et al. 1987). The combination of ethylene glycol and dimethyl
sulfoxide with sucrose was reported for mouse (Ishimori, et al. 1993) and bovine embryos
(Ishimori, et al. 1993), and form the basis of the vitrification protocol in assisted reproduction
treatment. By the end of the 1990’s, vitrification was being applied to human embryos with
high survival leading to blastocyst development and pregnancy establishment (Hsieh, et al.
1999). Lately there has been increased interest in cryopreservation of oocytes. The desire to
preserve fertility in young women undergoing gonadotoxic treatments or restrictions by
embryo cryopreservation in some countries including Bangladesh, El Salvador, Germany,
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Switzerland and Italy, has led to the necessity of oocyte donation or oocyte preservation for
fertility maintenance (Gook, et al. 2012). Many studies have shown that vitrification of
matured bovine oocytes have very high survival rates, and (Dalvit, et al. 2012) reported a 99%
survival rate after thawing. In the same study oocytes were matured and fertilized in vitro and
cultured to the blastocysts stage prior to vitrification. After thawing the morphology was
evaluated and showed 100% survival. The rest of the vitrified blastocysts were transferred to
recipient heifers, with fifteen heifers becoming pregnant which resulted in the birth of eleven
calves. Pregnancy rates with in vitro produced embryos showed no difference compared to
fresh blastocysts. Dalvit and others concluded that successful vitrification is possible when
using bovine oocytes and embryos. They further noted that the survival and developmental
rate are very similar to one another when comparing vitrified thawed oocytes and fresh
oocytes (Dalvit, et al. 2012). Vitrification normally consists of two to three solutions that are
prepared in TCM-199 with 10% fetal bovine serum (FBS). The equilibration solution consists of
a relatively low concentration of cryoprotectants which is then increased in the second or third
solution. These solutions also contain sucrose or trehalose as an extracellular cryoprotective
agent (Kuleshova et. al, 1999). A study done by Dutta and colleagues evaluated the post-thaw
developmental competence of vitrified bovine cumulus-oocyte complexes in vitro. Oocytes
were aspirated from three to eight millimeter ovarian follicles and cryopreserved via
vitrification (Dutta, et al. 2013). They used two vitrification solutions in TCM 199 and 10% FBS,
7.5% ethylene glycol and 7.5% dimethyl sulfoxide followed by 15% ethylene glycol, 15%
dimethyl sulfoxide and 0.6M sucrose. The immature oocytes were placed into the first solution
for three minutes followed by 30 seconds in the second solution at room temperature. The
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oocytes were then immediately loaded into 0.25mL French straws that were preloaded with
0.6M sucrose in the holding medium with air gaps in between and plunged directly into liquid
nitrogen. During the thawing stage straws were put into a 37°C water bath for 30 seconds and
were gradually rehydrated in 0.6M sucrose solution for one minute. After washing, the
morphology of the cells was assessed and put into vitro maturation. After 24 hours in the
maturation medium they were then subjected to in vitro fertilization. In the vitrified group in
vitro maturation on the basis of cumulus cells expansion was more than 80% and the unfrozen
control had 93% maturation showing that vitrification had minimal effect on the survival rates
and the ability of the oocytes to mature in vitro. High proportions of the oocytes retained
their post thaw morphology after short exposure to high concentrations of permeating
cryoprotectants with sucrose. Overall this protocol for vitrification had minimal effects on
survival rates and the ability for the oocytes to mature in vitro (Dutta, et al. 2013).
Different procedures and protocols work as well and solution concentrations can be
variable, and the amount of time in each solution may differ, as a single optimum protocol has
not been established. In another study, Luvoni evaluated the effect of vitrification of feline
ovarian cortex on follicular morphology and oocyte integrity, as well as meiotic competence.
Oocytes that were isolated from vitrified tissues were able to resume meiosis (39.8%), showing
that vitrification preserves the integrity of ovarian follicles and that oocytes that are taken
from cryopreserved tissues can maintain the ability to resume meiosis (Luvoni et. al, 2012).
Vitrification is technically simpler and may be more effective than slow freezing. In one study
by Cao slow freezing and vitrification were compared with evaluation of survival, early
embryonic development, fertilization, meiotic spindle assembly and chromosome alignment in
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frozen thawed human oocytes (Cao et. al, 2009). The oocyte survival in the slow cooling group
was significantly lower than those in the vitrification group and the fertilization rate was the
same for both groups. When looking at the cleavage rate the vitrified zygotes had a
significantly higher proportion than the slow cooling. Even when looking at the high quality
embryos the post-vitrification survival was double that seen with slow cooling, including the
percentage of blastocyst development. There was a much higher percentage of oocyte
abnormalities in terms of spindle assembly and chromosome alignment in the slow freezing
group. Overall vitrification was superior to the slow freezing method in terms of survival
fertilization and developmental rate for human matured oocytes in this study (Cao, et al.
2009). In comparison Prentice (2011) found that maturation rate was low in vitrified immature
Table 2.2 Survival and development rate of human pronuclear embryos cryopreserved by
slow cooling or vitrification using Cryotop method. (Derived from Valojerdi et al., 2009)
Slow Rate Freezing

Vitrification

Survived/ cryopreserved rate

1730/1944 (89%)

5881/5881 (100%)

Cleaved/surviving rate

1557/1730 (90%)

5469/5881 (93%)

Blastocyst/cleaved rate

7961/1557 (51%)

3058/5469 (56%)

Blastocyst/cryopreserved rate

7961/1944 (41%)

3058/5881 (52%)

bovine cumulus cell complexed oocytes compared to slow freezing controls, with cleavage and
blastocyst rates being higher in controls. Her results showed that the vitrification procedure
damaged the bovine cumulus cells oocyte complexes resulting in poor nuclear maturation and
embryo development (Prentice et. al, 2011). At present, approximately equal numbers of

19

babies have been born from both techniques (Noyes et. al, 2009). Table 2.2 shows the
differences between slow rate freezing and vitrification in Valojerdi (2009) study showing the
survival and development rate of human pronuclear embryos. These results showed that
vitrification may be the superior cryopreservation technique with human embryos (Valojerdi,
2009). It would appear that there is a role for both procedures today and in the future.
Vitrification is a fast, efficient, and economical method for oocyte cryopreservation providing a
new alternative for the management of female infertility and fertility preservation options.
CRYOPRESERVATION TOOLS
When vitrifying, it is ideal to minimize sample volume in order to achieve very rapid
cooling and warming rates. Cryopreservation would not be possible without a safe, secure
container for oocytes and embryos to be frozen in. There are many possible carriers to
minimize the volume of vitrification solution that is used today. The most common are open
pulled straw, cryoloop, cryotop, and cryolock. Cryotop systems consist of a fine, transparent
polypropylene film attached to a plastic handle and equipped with a cover straw, in which cells
can be loaded in a very small volume. Cryotops have been successfully used to cryopreserve
cow and buffalo embryos (Laowtammathron et. al, 2005) and oocytes (Chian et. al, 2004).
Open Pulled Straws (OPS) were especially designed for vitrification, and are an open system
allowing for even faster cooling rates. Techniques are categorized as either 'open' or 'closed'
according to occurrence of direct contact between the medium and liquid nitrogen during
cryopreservation. Scientists who use open systems refer to the lack of evidence of disease
transmission in an open system and regard their systems as more consistent and efficient
(Vajta et. al, 2015). Cells can also be packaged into straws, which are then sealed on both ends
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before plunging into liquid nitrogen to ensure that contamination is prevented. When
comparing cryotops to open pulled straws a lower percentage of those oocytes vitrified in the
open pulled straw had a normal spindle configuration compared to fresh oocytes, while
normal spindle and chromosome configurations were observed more consistently in the
cryotop vitrified bovine oocytes. This suggests that the cryotop system is a more efficient
carrier for vitrification of bovine oocytes than open pulled straws (Morato et. al, 2008). The
cryoloop method is a new technique where a thin nylon loop is used to suspend a film of
cryoprotectant containing the oocytes to directly submerge them in liquid nitrogen. The loop
shows minimal diffraction, is thin for fast freezing and is aerodynamic. In one experiment the
cryoloop vitrification method produced a survival rate of 90.5% compared to the traditional
slow freezing technique that yielded a rate of 54.4% (Mavrides and Morroll, 2002). Cryolock is
a square shaped stick, with four flat surfaces. It has a concave tip, where the cells, oocytes or
embryos are placed, it provides protection to the cell against contact with other surfaces,
avoiding loss or damage of samples. During slow rate freezing there are many tools needed
that include a secure container for oocytes and embryos to be frozen in. This is normally an
0.25mL straw that contains a plug, as a straw is needed for the programmable freezer control
unit. In most programmable freezers, the straws are cooled by nitrogen vapor. The
temperature inside the cooling chamber can be accurately controlled and the time course of
the temperature can be programmed. The rate of heat exchange is governed by the
temperature difference between the inside and the outside of the straw (Sansienen et. al,
2010) . When using both techniques the tools are very important aspects that need to be
evaluated before cryopreservation. The freezing process is not the only concern for harmful
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effects on the cell, there are many factors that can change the viability. One main issue with
vitrification and slow rate freezing is the thawing process after vitrification and slow rate
freezing.
WARMING
Freezing cells allows them to be stored for years in a state where their normal
metabolic activity is suspended to protect them from damage from chemical reactivity and
time (Simione, 2009). The cells can then be warmed and resuscitated as needed. The thawing
and rewarming process after the storage of oocytes and/or embryos also has a very important
role for the survival rates (Schellander et. al, 1994). Time is the most important factor when
warming cells. These cells are extremely fragile and need gentle handling and immediate
settlement into a pre-warmed culture medium. Some cell types are more sensitive than others
to the freezing process (Felipe de Lara Janz et. al, 2011). Not only do the cells need to be
handled properly to ensure consistency and sterility but also to ensure a correct choice of type
and amount of cryoprotective agent added (Tucker, 2007). On thawing, oocytes have to be
rehydrated and the intracellular cryoprotectant needs to be removed. The extracellular agents,
like sucrose, have been shown to have a beneficial influence during removal of the
cryoprotectants (Yokoyama et. al, 2012). As explained previously, freezing can cause cellular
injury, resulting in cell death, especially from -15°C to -30°C (Djuwantono et. al, 2011) and cells
will pass through this critical range twice, once during freezing and again at thawing.
Depending on what cryopreservation tool is used, the thawing protocol will be altered. When
using straws, they will be immediately submerged in a 37°C water bath and then oocytes will
be removed into a dilution solution. If on a cryolock or cryotop, the cap will be removed and
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the stick itself will be placed into a warmed or room temperature dilution solution. Generally,
cells should be thawed quickly to avoid ice crystal formation but diluted slowly to remove the
intercellular cryoprotectant while preventing osmotic shock (Tucker, 2007).
EMBRYOS
The preservation of female genetics can be done through the preservation of the
germplasm. Germplasm refer to the tissues maintained for the purpose of animal breeding,
preservation, and other research uses. These resources can be animal breeding lines
maintained in a breeding program. Gametes can be collected at different developmental
stages using many different techniques including post ovulation flushing, transabdominal
laparoscopic surgery, transvaginal uterine flushing, or trans rectal ovum pick up (Arav, 2014).
These procedures may be performed during a natural estrous cycle, following chemical
stimulation to achieve superovulation, or after fertilization at various developmental stages
before embryo implantation. The first reports on successful embryo cryopreservation were
published in 1971 by Whittingham (Whittingham, 1971) more than two decades after Polge
reported success in freezing spermatozoa in 1949 (Polge and Parkes, 1949). Embryo freezing
has the ability of preserving both parents genetic background. In wild animals, especially with
endangered species, this is often nearly impossible, and the opportunity to collect oocytes or
embryos is very rare, such that researchers find it helpful to use laboratory, farm, or
companion animals as model species during the process of developing the necessary
reproductive techniques associated with embryo cryopreservation. According to a recent
report by the International Embryo Transfer Society, over 300,000 frozen thawed bovine
embryos were transferred in 2008 worldwide (Thibier, 2009). This success was motivated by
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three primary factors, the availability of financial resources to support an increasing number of
studies, the availability of an unlimited flow of oocytes from slaughterhouses that make
studies possible, and the fact that non-surgical collection of embryos is possible in cattle via
flushing (Saragusty, 2011). Regardless of many advances in the field of embryo
cryopreservation, there is still no agreement as to the ideal developmental stage for embryo
cryopreservation. Factors that have an impact on fresh embryo transfer have a comparable
effect on the transfer of frozen thawed embryos. In humans, patient age at the time of
freezing influences pregnancy outcome due to poorer quality of oocytes collected from aged
females, often due to aneuploidy (Sherbahn, 2011). The number of embryos transferred and
the quality of embryos impact the outcome, in both frozen and fresh embryos (Burks et. al,
2015). When research on human embryos is performed, the ethical questions arise whether
we are doing research on unborn children and killing them (Beca et. al, 2014). To reduce any
religious or moral issues the cryopreservation of oocytes was evaluated and has been shown
to be successful.
MATURE OOCYTES
Maturation of the oocyte in a follicle depends on the progress of the maturation of the
surrounding follicle cells. The oocyte is arrested for an extended time at the diplotene stage of
the first meiosis and now will prepare itself for meiosis completion due to the triggered
luteinizing hormone peak and the dominance of the follicle (Senger, 2005). Within the oocyte,
the completion of the first meiosis is initiated by the ejection of the first polar body and the
beginning of the second meiosis starts and arrests in the metaphase stage. The start of meiosis
II is also known as the equational division (Senger, 2005). The end result is the production of
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four haploid cells from the two haploid cells produced in meiosis one. First they go through
prophase II, the nucleoli and nuclear envelope start to disappear, along with the shortening
and thickening of the chromatids (Senger, 2005). Centrosomes move to the polar regions and
arrange on the spindle fibers (Raven et. al, 2016). Centromeres attach to the spindle fibers
from the centrosome at the opposite poles in metaphase II and will not continue until
fertilization occurs (Raven et. al, 2016). The most characterized cytoskeletal damage by
cryopreservation via slow cooling and vitrification concerns the disruption of sub-cortical actin
network, microtubule depolymerization, abnormal spindle configuration and chromosome
scattering within mature oocytes and therefore compromising the ability to develop into a
viable embryo (Ferris et. al, 2015). One experiment, published by Huang, demonstrated that
there is no significant difference in post-warming survival, normal spindle morphology,
chromosome alignment and incidence of aneuploidy between in-vitro and in-vivo matured
murine oocytes (Huang, 2008). Nonetheless, he did display that oocyte in vitro maturation and
vitrification did decrease the cleavage and blastocyst formation rates compared to in vivo
matured mouse oocytes after vitrification (Huang et. al, 2008). The reduced development is
most likely an effect of an increase in DNA fragmentation occurring in the in-vitro matured
oocytes, likely caused by suboptimal culture conditions (Huang et. al, 2008). Mature
metaphase II mouse oocytes were divided into two groups and cryopreserved via slow freezing
and vitrification in a study completed in early 2015. After thawing, the oocytes were observed
for survival and fertilization, and were also compared to investigate the effect of both
protocols on spindle reassembly and chromosome configuration at different times during
warming. Survival rates were higher for vitrified oocytes as compared to slow frozen oocytes.
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The morphology of the meiotic spindle was found to be in a disorganized configuration in slow
frozen oocytes at all time points whereas in vitrified oocytes the spindles were found to be
aligned at all-time points. Chromosomes were seen to be displaced from equatorial region in
both groups (Jadoon, et al. 2015). This shows that vitrification may be a better protocol when
using mature metaphase II oocytes but can the same be said to be the same with immature
germinal vesicle oocytes?
IMMATURE OOCYTES
In immature oocytes the microtubules are not yet organized in the metaphase two
spindle formations. Therefore, cryopreservation at this stage bypasses the risk of chromosome
abnormalities as the chromatin is decondensed and is still protected by the nuclear envelope
(Senger, 2005). Female gametes are normally cryopreserved as cumulus oocyte complexes
(COC), with the surrounding cumulus cells which are small and numerous and are easy to
freeze (Schellander et. al, 1994). In the late 1980s, it appeared that the oocyte was too
vulnerable to cryopreserve at the metaphase II stage and animal work shifted to evaluating
slow rate freezing of germinal vesicle oocytes, but little was published (Jain and Paulson,
2006). High survival could be accomplished with mouse germinal vesicle stage oocytes (Van
der Elst, 1992) but some studies observed reduced overall development (Schroeder et. al,
1990), this suggested that there was no total benefit to cryopreserving at the germinal vesicle
compared with the metaphase II stage. In many studies it has been shown that cryopreserving
immature oocytes harms the ooplasm (Kim et. al, 2014), potentially due to inadequate
conditions of in vitro maturation or basic oocyte defects. In a study led by Coticchio, they
explored the possibility that the DNA of immature oocytes may be damaged and that the
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inability to trigger a repair action is associated with the germinal vesicle arrest. They found
double strand DNA breaks in these oocytes, and hypothesized that this may be an important
factor affecting the meiotic resumption (Coticchio et. al, 2015). It was demonstrated that
immature bovine oocytes are very sensitive to low temperatures from 0 to 4°C, with an
abnormal meiotic spindle formation that inhibits the normal development of oocytes after in
vitro fertilization (Wu and Leibo, 1999). There are still many flaws with the experimental
designs when using immature oocytes for patients undergoing fertility treatments. Such that,
with current protocols it may be best to cryopreserve mature oocytes after in vitro maturation
to metaphase II (Combelles et al. 2012). Cryopreserving after maturation to metaphase II still
leaves us with the issue of the spindle fibers being damaged during cryopreservation by ice
crystal formation. Oocyte freezing is more advisable for patients with personal, moral, or
religious objections to the cryopreservation of embryos as oocyte cryopreservation would
eliminate many of these ethical and legal implications. It is much more acceptable to discard
frozen oocytes rather than frozen embryos.
IN VITRO EMBRYO PRODUCTION
In vitro maturation and in vitro fertilization are both steps in the in vitro embryo
production process. In vitro maturation is a precursor to in vitro fertilization when using
immature oocytes. In vitro maturation is an optional step depending on the state of the
oocytes at retrieval: with in vitro fertilization, the oocytes are normally matured inside the
ovaries, while in in vitro maturation the immature oocytes are removed and then are matured
outside the body. In vitro maturation requires no hyper stimulation of the ovaries. Once the
immature oocytes are removed, they are placed in a petri dish and exposed to a combination
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of luteinizing hormones and follicle stimulating hormones. The oocytes are usually left in this
medium for 22 to 24 hours; once they have reached maturation, they are then inseminated
normally (by IVF) or by intracytoplasmic sperm injection (ICSI) for fertilization of the matured
oocytes (Lim et. al, 2013). The developing embryos are then transferred back into the uterus
within four to seven days. While the success rates for in vitro maturation are better than in the
past, they are still lower than those for in vitro fertilization following in vivo maturation.
Pregnancy rates differ based on a few factors, the most important being the age of the
females’ oocytes (Sherbahn, 2011). In humans, a typical 35-year-old woman, with no major
health problems, can normally have a 40% success rate for a single cycle of in vitro fertilization,
compared to 32% with in vitro maturation (Abma et. al, 1997). A full cycle of in vitro
fertilization can cost as much as $30,000, while a full cycle of in vitro maturation is closer to
$6,000 and often both procedures need to be repeated before pregnancy occurs (Abma et. al,
1997). In vitro maturation is clearly a safer alternative than using in vivo matured oocytes for
in vitro fertilization in patients’ sensitive to gonadotropins. In vitro maturation may be the
procedure of choice not only for infertile couples but also for obtaining oocytes for
preservation of fertility. In vitro maturation is a good alternative in fertilization preservation in
cancer patients. The process of in vitro maturation can be conducted safely even with patients
who are hormone sensitive. In vitro maturation could be a key method used for patients who
are soon to be using cancer therapy since there is no interruption to treatment for ovarian
stimulation (Lim et. al, 2013).
In vitro fertilization is the combination of an oocyte with a sperm cell in a petri dish to
achieve successful fertilization. In vitro fertilization is a common assisted reproductive
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technology, the first successful in vitro fertilization and birth of live offspring using frozen
thawed mouse oocytes was reported in 1976 (Parkening and Chang, 1976). The process of in
vitro fertilization is very basic; often beginning with super ovulation of the female to obtain
mature oocytes. This can be done with hormonal injections; follicle stimulating hormone,
luteinizing hormone, prostaglandin and others (Yenkie and Diwekar, 2014). Super ovulation
helps the female mature more than one oocyte in a cycle to optimize retrieval rates.
The second step is harvesting the oocytes which can be done through multiple
methods; surgically exposing the ovary and aspirating the follicles, non-surgically aspirating the
follicles utilizing ultrasonography and a hypodermic needle, and aspirating follicles
postmortem (Lai et. al, 2015). The most common technique for recovery of oocytes by
aspiration in equids involves inserting a needle through the vaginal wall and the use of an
ultrasound. This helps identify the dominant follicles before aspirating the oocytes into a
special apparatus, such as a filter (Ulloa et. al, 2015). With humans it is done through a minor
surgery of inserting a thin needle through the vagina and into the ovary and follicles that
contain the oocytes. This needle is connected to a suction device which then pulls the oocytes
and the fluid out of each follicle, one at a time (Ulloa et. al, 2015). The procedure with bovine
is very similar, it is done the same way but investigators go rectally to grasp the ovary and then
go in vaginally with the ultrasound and follicle aspirator to remove the oocytes from the
ovaries (Ulloa et. al, 2015).
The next step is insemination and fertilization; sperm cells that have good motility and
morphology are selected and then placed with the best quality oocytes. To isolate the best
quality bovine sperm cells they are put into a percoll gradient and centrifuged down multiple
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times. There is two-layer density gradient which separates the motile and non-motile sperm
cells. The fast and well moving sperm cells will be able to swim down through the lower
gradient, but the poor cells will be trapped in the gradient interface (Guimaraes et. al, 2014).
To determine the best quality oocytes, the amount of cumulus cell layers is evaluated. More
layers of cumulus present are associated with increased transfer of necessary factors to the
oocytes to fertilize and grow throughout the in vitro fertilization process (Tetsuka et. al, 2015).
The fourth step consists of monitoring the embryo, to make sure it is growing properly.
The embryo will be dividing rapidly at this time and by day seven the embryo will be ready for
transfer (Moreno et. al, 2015). To transfer an embryo a catheter containing the embryos is
inserted into the vagina, through the cervix, and up into the uterus. Pregnancy occurs and is
successful if an embryo sticks and is implanted in the lining of the uterus and grows (Moreno
et. al, 2015). Choosing embryos with the highest developmental potential is one key step to
overcoming the hurdle of early embryonic mortality. The success of the development of the
embryo is highly complex and depends on both the embryo quality and the maternal
receptivity. (Tanabe and Hasler, 1985) Oocyte quality is another important factor to the health
of the embryo (Dumesic, 2015). Regardless of these factors, the survival depends on the
delicate placement of the embryos at the proper location. The first successful embryo transfer
was done in a rabbit in 1890 by Walter Heape (1890), and began in food animals in the 1930s
with sheep and goats (Warwick and Horlacher, 1934) and later in cattle (Chang, 1951) and
swine (Day and Melampy, 1959) in the 1950s. Commercial and non-invasive embryo transfers
in the United States began in the early 1970s and continues to thrive (Moffit, 1979). Pregnancy
rates are generally around 60% with fresh embryo transfer and 50-60% with frozen thawed
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embryo transfers (Galliano et. al, 2015). In cattle there are about 150,000 potential oocytes
(Selk, 2016) in the female but in natural breeding only a fraction of the reproductive potential
of a single cow can be realized. Embryo transfer is a technique that can greatly increase the
number of offspring that a genetically superior cow can produce.
CURRENT ISSUES FOR FUTURE RESEARCH
The global diversity of domestic animals is considered to be under threat, a large
number of domestic animals worldwide are endangered or in critical status. In farm animals,
trends in within-breed diversity are as significant as between-breed diversity that are in
demand to be able to manage with changing requirements. These would include the
requirements in breeding and the selection process. Cryopreservation of germplasm is a smart
strategy to conserve existing diversity for future use commercially and in rare breeds. There
are studies (Baka et. al, 1995) (Combelles and Chateau, 2012) (Fasano et. l, 2014) that not only
affect our domestic and wild species but humans as well. Although over one hundred babies
have been born from oocyte storage, pregnancy rates still remain low (Cobo et. al, 2015).
Others problems beyond intracellular ice formation and osmotic effects need to be identified.
The ability to cryopreserve human oocytes and store them would be beneficial for cancer
patients, since there is a risk of these patients becoming sterile after therapy (Barcroft et. al,
2013). It would also be beneficial for women who want to delay reproduction and to alleviate
religious concerns dealing with embryo storage. Studying and experimenting with domestic
animal species’ oocytes and sperm cells will help us in the future with our own reproduction
issues.
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New methods that include vitrification have proven useful in increasing the survival and
pregnancy rates of oocytes and embryos. There are other methods that have not been tested
yet, including different protocols, processes and solutions, cryoprotectant concentrations and
others with both immature and mature oocytes. The study and research of vitrification
protocols has led to the formation of new ideas and has demonstrated the flexibility of cells to
survive cryopreservation. In general, further advances are needed to improve the storage of
human oocytes before a widespread routine is used in clinics worldwide. The use of animal
oocytes and embryo will help resolve these issues and find an optimal cryopreservation
protocol when utilizing immature and mature cumulus cell complex oocytes.
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CHAPTER III
VITRIFICATION OF BOVINE IMMATURE AND MATURE CUMULUS CELL OOCYTE COMPLEXES

INTRODUCTION
In vitro production can be maximized through the use of cryopreservation for long term
oocyte storage (Shaw 2000). Cryopreserving of mature oocytes can result in damage to the
metaphase spindle due to the temperature sensitivity of the microfilaments and microtubules
as well as other morphological issues (Baka et. al, 1995). In 2008 Huang observed a decrease in
cleavage and blastocyst formation of murine IVM oocytes after vitrification compared to in
vivo oocytes (Huang et. al, 2008). In addition, Jadoon and others concluded the meiotic spindle
of mature metaphase II mouse oocytes after cryopreservation were disorganized and
displaced (Jadoon, et al. 2015). Cryopreservation of immature oocytes may circumvent this
problem because these structures have not yet formed and the genetic material is enclosed
within a nuclear envelope (Benson, 2008). However, Kim demonstrated that cryopreserving
immature rat oocytes may harm the ooplam leading to reduced development and compromise
cell cycle status compared to fresh control oocytes (Kim et. al, 2014). The use of different
cryoprotectants can also affect the viability of each specific cell type for the freezing and
warming process. DMSO and glycerol are the most commonly used cryoprotectants but have
mixed results of specific cell types and sizes. Si and colleagues found that glycerol at
concentrations below 5% in comparison to 15% dimethyl sulfoxide led to improved post-thaw
survival (Si, 2004). However, Lim and colleagues showed that IVM bovine oocytes were more
morphologically normal, had higher spermatozoa penetration rate and higher percentage
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developed to 2-cell stage at 48 h postinsemination when cryopreserved with 1.0 M DMSO
versus 1.0 M glycerol (Lim et. al, 1999)
The aim of these experiments was to determine if immature and mature cumulus cell
complexes cryopreserved via vitrification with dimethyl sulfoxide and glycerol solutions would
remain viable following thawing and in vitro fertilization, as indicated by pronuclei formation.
The specific aim was to vitrify immature germinal vesicle stage COC in different
cryoprotectants to determine differences in survival, as assessed through post thaw oocyte
maturation and fertilization rates with mature oocytes after in vitro fertilization. The second
aim was to vitrify mature M2 stage COC in different cryoprotectants with an endpoint
including post thaw oocyte fertilization rates in mature oocytes after in vitro fertilization. We
hypothesized that DMSO would yield higher survival and fertilization rates than glycerol for
both immature and mature bovine oocytes. We also hypothesized that immature bovine
oocytes would fertilize at a higher rate than mature oocytes after vitrification and IVF.
An experiment conducted in 2013 determined if immature oocytes cryopreserved by
vitrification and slow rate freezing would resume meiosis upon thawing (Hardin et. al, 2013).
There were two separate experiments in this study, comparing vitrification and slow rate to
one another with controls. Within the first experiment oocytes were cryopreserved via slow
rate freezing process using 10% ethylene glycol. The second experiment was subjected to
vitrification in a three step process using glycerol and ethylene glycol (10% glycerol for 5
minutes, 10% glycerol and 20% ethylene glycol for 5 minutes then 24% glycerol and 26%
ethylene glycol for 45 seconds). Upon thawing and IVM the results in the slow rate freezing
group yielded oocytes matured to the metaphase two stage at the same rate as the controls
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(45% and 55% respectively P = 0.44). Within the vitrification group the cryopreserved oocytes
matured to the metaphase two stage at a lower rate than the controls (49% and 79% P = 0.01).
This experiment indicated that immature cryopreserved oocytes would resume meiosis
following warming while vitrified immature oocytes matured at a lower rate than controls
under these conditions. These unexpected results gave us motivation to further investigate
vitrification on immature bovine oocytes.
MATERIALS AND METHODS
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich Chemical Co.
(St. Louis, MO, USA).
EXPERIMENTAL DESIGN
Oocytes from Angus cross cows located in St. Gabriel, LA at the LSU Reproductive
Biology Center were collected by transvaginal ultrasound-guided follicular aspiration (TUGA)
and vitrified immediately as immature oocytes (experiment one). On a separate collection day
oocytes were placed into maturation immediately after OPU and prior to manipulation
(experiment two). A total of 200 mature oocytes and 200 immature oocytes were collected
and vitrified in DMSO and glycerol treatment groups in both experiments.
EXPERIMENT ONE DESIGN
Oocytes were vitrified using two cryoprotectants solutions on cryolocks immediately
after collection and stored in liquid nitrogen for at least seven days (Table 3.1). After
vitrification and storage, oocytes were thawed in the dilution solution for 5 minutes (Table
3.4), washed with HEPES-TALP and placed in 40 µL droplets of standard IVM medium
consisting of M199 supplemented with 10% fetal bovine serum (FBS), 0.2 mM sodium
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pyruvate, 1% pen/strep, 2 mM glutamine, and FSH (5.0 μg/mL) (Appendix B) covered with
mineral oil. Following maturation for 22 hours within the 5% CO2 incubator, 10% of the
oocytes were evaluated for maturation rate by fixation in 3:1 methanol acetic acid for at least
48 hours and stained with aceto orcein. The remaining oocytes were placed into standard IVF
for fertilization for 18 hours in a 5% CO2 incubator. After 18 hours they were vortexed in 1
mg/mL hyaluronidase solution and put into global 35+ droplets covered with oil and cultured
for 24 hours. They were then stained with Hoechst 33342 and evaluated to determine their
pronuclei formation, then fixed and stained in acetic orcein for further evaluation.
EXPERIMENT TWO DESIGN
Aspirated oocytes were put into 40 µL droplets of standard IVM medium covered with
mineral oil immediately after collection and prior to vitrification in 5% CO2 incubator for 22
hours. Following maturation, 10% of the oocytes were evaluated to determine maturation rate
by fixation in 3:1 methanol acetic acid for at least 48 hours and staining with aceto Orcein
(Appendix A and B). The remaining oocytes were then vitrified using DMSO and Glycerol
cryoprotectant solutions, shown in table 3.1 (5 minutes in the first solution and 45 seconds in
the second solution) (Appendix A and B) on cryolocks and stored in liquid nitrogen for at least
seven days. After vitrification and storage, all oocytes in both cryoprotectant groups were
thawed in an 0.025M sucrose dilution solution shown in table 3.2 for 5 minutes and washed
with HEPES-TALP (Appendix B). Oocytes were then placed into standard IVF (see Appendix A
and B) for fertilization in 5% CO2 incubator for 18 hours. After 18 hours they were then
vortexed in 1 mg/mL hyaluronidase solution (Appendix B) and put into global 35+, embryos
culture media (Life Global) droplets covered with oil for 24 hours. They were then stained and
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evaluated using Hoechst 33342 (Appendix A and B) to determine pronuclear formation and
then fixed to be stained in acetic orcein for further evaluation.
Table 3.1 Composition of Cryoprotectant Solutions for both Treatments
Vitrification Solutions for Glycerol Treatment

Vitrification Solutions for DMSO Treatment

Vitrification One

Vitrification Two

Vitrification One

Vitrification Two

PBS

PBS

PBS

PBS

20% Calf Serum

20% Calf Serum

20% Calf Serum

20% Calf Serum

10% Ethylene Glycol

20% Ethylene Glycol

10% Ethylene Glycol

20% Ethylene Glycol

10% Glycerol

20% Glycerol

10% DMSO

20% DMSO

0.5 M sucrose

0.5 M sucrose

0.5 M sucrose

0.5 M sucrose

Table 3.2 Dilution Solution for both Experiments for both Treatments
PBS

16 mL

20% Calf Serum

4 mL

0.025 M Sucrose

0.855g

IVF VALIDATION
As validation of the IVF system, we received matured oocytes from a commercial
source DeSoto Biosciences (TN). Oocytes went into IVF-TALP (Appendix A and B) 20-30 per well
with percoll separated sperm cells and incubated in 5% CO2 for 18 hours. After 18 hours they
were vortexed in hyaluronidase and put into 50 µL droplets of global 35+ medium covered in
oil until the next morning. All oocytes were then stained and evaluated using Hoechst 33342 to
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determine pronuclei formation and then fixed and stained in acetic orcein for further
evaluation.
PREPARATION
Required media included Dulbecco’s Phosphate Buffered Saline (D-PBS), Hepes TALP,
standard maturation medium, dimethyl sulfoxide vitrification solution, glycerol vitrification
solution, dilution solution, standard fertilization medium and culture medium (Appendix B)
was prepared the day prior to use. On the afternoon before oocyte collection, D-PBS was
placed in the incubator to warm overnight. 10 mL of bovine calf serum (BCS) and 1 mL of
Heparin (Sagent Pharmaceuticals, Schaumburg, IL, USA) were added to the D-PBS the morning
of collection. HEPES-TALP holding media for the control and treatment groups consisted of 20
mL HEPES-TL (Caisson Labs, North Logan, UT, USA) with 60 mg BSA and 200 μL sodium
pyruvate and pen/strep (Gibco, No.15140).
On the afternoon before oocyte collection, all necessary media dishes were prepared
with premade solutions and equilibrated for at least two hours in the incubator before being
used. Petri dishes (35mm, BD Falcon) of HEPES-TALP and D-PBS were placed in a non-CO2
incubator at 39ᵒC to warm 2 hours prior to oocyte collection, for washing, and sorting into
treatment groups. 500 µL of fertilization media was put into a 4 well dish and water put into
the center on the dish. Both maturation and fertilization media were then placed into a 37°C
5% CO2 incubator for at least 2 hours prior to adding oocytes, to allow for equilibration.
Fixation media was a 3:1 solution of methanol acetic acid and was added before staining in
aceto orcein.
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OOCYTE COLLECTION
These experiments consisted of 9 collection days, four for experiment one and five for
experiment two. Oocytes were collected from follicles three to eight mm in diameter by
transvaginal ultrasound-guided follicular aspiration. Oocytes from all aspirations on a given day
were pooled and transferred to a 35 mm dish containing pre-warmed HEPES-TALP holding
medium. Oocytes were randomly assigned to one of the two treatment groups: dimethyl
sulfoxide or glycerol cryoprotectant solution. Each collection day was pre-determined to be an
immature or mature oocyte group. Following collection oocytes were either matured or
vitrified following above outlined procedures in accordance with the allocated groups for that
specific day.
TRANSVAGINAL ULTRASOUND-GUIDED FOLLICULAR ASPIRATION
Oocytes were obtained with TUGA (Figure 3.1) at the LSU AgCenter, Reproductive
Biology Center in St. Gabriel, LA. Each cow was held within a holding chute and given an
epidural injection of 5 mL lidocaine (Vet One, Product No. 510212) between vertebrae near
the base of the tail. An ultrasound probe with a 7.5 MHz transducer was inserted into the
vaginal canal, and the ovary was held through the rectum and placed against the vaginal wall
along the transducer at the end of the ultrasound probe. The ovary was observed on an
ultrasound monitor and the follicles were identified. An 18-gauge disposable collection needle
inside the ultrasound probe was connected to a suction pump via polyethylene tubing, after
good visualization of the follicle with the ultrasound, the collection needle was advanced
through the vaginal wall and into the follicle, the follicular fluid along with the oocytes were
aspirated via suction. The tubing and needles were rinsed with collection media after each
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ovary and the needle changed after each cow, the follicular fluid and oocytes were deposited
into an embryo collection filter (Agtech Inc., Manhattan, KS, USA). All media were maintained
at 39°C during collection with a heated tube holder. After collection of two cows the tubing
and needles were rinsed with collection media (D-PBS with heparin and BCS) and all fluid
filtered and poured into a search dish. Oocytes were located and placed into a warmed 35 mm
dish containing HEPES-TALP.
Following collection, all oocytes were then placed into a 1mL micro centrifuge tube
containing warmed HEPES-TALP and transferred to the Animal and Food Science Laboratory on
Louisiana State University campus.

Figure 3.1 Diagram of transvaginal ultrasound-guided follicular aspiration. (Drawing
by E. Meintjes, 1995)
VITRIFICATION AND WARMING PROCEDURES
Oocytes in both maturation groups were vitrified in both dimethyl sulfoxide and
glycerol cryoprotectant groups. Oocytes, within each day were randomly assigned to glycerol
or DMSO group for vitrification. Groups of two to five oocytes would be placed into the
designated equilibration solution for 5 minutes (Figure 3.2). They were then transferred to the
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higher concentration vitrification solution, placed on the cryolock device (Figure 3.3), excess
media removed and plunged into liquid nitrogen within 45 seconds (Figure 3.2). The tops to
the cryolocks were put on with forceps after being plunged into liquid nitrogen. The immature
group of oocytes would go through the same procedure without maturation beforehand. They
were transferred to the Food and Animal Science Laboratory Building in HEPES-TALP and
vitrified immediately.
After the oocytes were stored in the liquid nitrogen for at least seven days, the
cryolocks were removed from the canisters, the tops removed and the vitrified oocytes on the
cryolocks were immersed directly into a petri dish containing the warmed dilution solution and
were kept there for 5 minutes to insure all cryoprotectants were removed from the ooplasm.
Oocytes that had been thawed were then rinsed in HEPES-TALP. Matured oocytes were then
washed in IVF-TALP and then placed into 48 µL droplets of IVF-TALP. The oocytes were in
groups of 10-12 per droplet, in a 35mm dish that was being held within the 5% CO2 incubator
at 37ᵒC two hours prior to fertilization. Immature oocytes went through maturation prior to
IVF.
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Figure 3.2 Cryolock vitrification and warming procedure for both experiments.

Figure 3.3 One denuded bovine oocyte loaded onto Cryolock device (indicated by arrow)

IN VITRO FERTILIZATION
In vitro fertilization was performed using spermatozoa from multiple batches of semen
from a single Angus bull of proven fertility that had been frozen in straws, from Genex. One
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0.25 mL straw of frozen semen was thawed in a 39°C water bath for 30 seconds. Semen was
separated on percoll gradient (Irvine Scientific 99264) and washed three times using IVF- TALP
by centrifugation at 400 x g for 20 minutes starting at 37°C and reducing to 25°C, 10 minutes
and 5 minutes consecutively. Each time the sperm pellet was re-suspended with a reducing
amount of IVF-TALP. After the last suspension, the IVF-TALP was aspirated down to the sperm
pellet and the appropriate amount of IVF-TALP was added to reach a final concentration of 1 x
10^6 sperm/mL. 20 µL of the final sperm suspension was added to each well of oocytes and
IVF-TALP within a 5% CO2 incubator at 39°C for 18 hours.
Example: 7500/X = µL of sperm; 300- µL of sperm = amount of IVF-TALP
Sperm morphology was evaluated by adding 95 µL of water to 5 µL of the sperm pellet
to a micro centrifuge tube and gently mixing. 10 µL of sperm dilution was added to each side
of the hemocytometer and sperm was counted. Sperm mobility was also estimated post thaw,
by looking under a microscope.
STAINING AND DATA COLLECTION
All oocytes were placed into Hoechst 33342 (5 µL with 500 µL HEPES) for 10 minutes.
They were then rinsed in HEPES-TALP and 8-10 embryos were transferred to a microscope
slide with minimal media, and mounted on the slide with a cover slip. They were observed
with an epi-fluorescent microscope equipped with UV excitation and appropriate barrier filters
using Hoechst 33342, 42 hours after IVF.
STATISTICAL ANALYSIS
This experiment consisted of 9 replicates, 5 mature oocyte groups and 4 immature
oocyte groups. Assessment of oocyte viability was based on morphology, the fertilization rate
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as indicated by cleavage, and development rate was compared within respective parameters
using Fisher Exact Test. Means with a probability value of P< 0.05 were considered significantly
different.
RESULTS
EXPERIMENT ONE
IVF results of immature oocytes after vitrification in the DMSO treatment group had
8.49% fertilization rate compared with 0% oocytes in the glycerol group, seen in Table 3.3.
There was no statistical difference between DMSO and glycerol fertilized oocytes with the Pvalue of P= 0.0056 due to low numbers of oocytes fertilized (DMSO 9/106). The results for
both treatment groups did show a proportion of the oocytes having polyspermy fertilization
(3.77% and 3.70%).
Table 3.3 Nuclear status of Immature Oocytes after IVF with DMSO (N=106) and Glycerol
(n=81)
DMSO % (no.)

Glycerol % (no.)

P value

Matured ᴬ

12.26% (13/106)

2.47% (2/81)

0.0149

Fertilized

8.49% (9/106)

0%

0.0056

Immature

0%

1.23% (1/81)

0.4332

Polyspermy

3.77%(4/106)

3.70% (3/81)

1.0000

Degenerate

74.04% (77/106)

80.49% (66/81)

0.1688

Indeterminate

11.54%(12/106)

7.32% (9/81)

1.0000

ᴬ Oocytes matured includes oocytes fertilized
*Proportions with a probability value of P<0.05 were considered significantly different
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Results also demonstrated that some proportion of oocytes became matured (12.26%
and 2.47%) after vitrification in both treatment groups and showed a significant difference the
two (P=0.0149) but were not able to become fertilized. Results also show a small proportion of
oocytes still immature (1.23% Glycerol) after vitrification, IVM and IVF, signifying that
vitrification could be interfering with the resumption of meiosis. The majority amount of the
oocytes was degenerate (74.04% DMSO 80.49% glycerol) and some were indeterminate
(11.54% DMSO 7.32% glycerol) (as described in oocyte analysis). The numbers, proportions
and P-values can be seen in Table 3.3. Pictures taken after Hoechst 33342 and Acetic Orcein
staining can be seen in Figure 3.4 of both treatments groups within the first experiment
illustrating different nuclear maturation observed after IVF.

Figure 3.4 Different stages of nuclear maturation of Immature DMSO (A) and Glycerol (B)
cryoprotectant treatments.
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Oocytes were analyzed (Table 3.3), for nuclear status and development following
fertilization, pictures as followed in Figure 3.4. The indication of fertilization included
formation of two pronuclei. Matured oocytes had either one pronucleus, a metaphase two
plate or were anaphase stage (detailed tables found in Appendix C). Immature group indicated
oocytes in metaphase one, and polyspermy means polyspermy fertilization occurred. The
degenerate variable means that the oocytes were dead. The indeterminate variable means
that the oocytes were unknown, had sperm heads and/or cumulus cells interfering with
visualization (detailed tables found in Appendix C).
EXPERIMENT TWO
Mature oocytes had fertilization in both cryoprotectant treatment groups after
vitrification and IVF, but with low proportions in both treatments, DMSO 12.62% fertilized and
glycerol 3.4% seen in Table 3.4. There is a statistically significant difference between the two
cryoprotectants with a P-value of 0.0335. The results for the glycerol treatment group did
show a proportion of the oocytes having polyspermy fertilization (3.4%) but none in the DMSO
group. The results also revealed that a decent portion of oocytes were still mature after IVF in
both treatments (29.12% DMSO and 13.63% glycerol) and showed a significant difference
(P=0.0136). There were also some oocytes that did not mature after IVM and prior to
vitrification that were designated as immature oocytes. The majority of the oocytes were
degenerate or indeterminate (as described in oocyte analysis). Pictures taken after Hoechst
33342 and Acetic Orcein staining can be seen in Figure 3.5 with treatments groups within the
second experiment illustrating different nuclear maturation observed after IVF.
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Oocytes were analyzed (Table 3.4), for nuclear status and development following
fertilization. The indication of fertilization included formation of two pronuclei and included
three cell and four cell embryo development as seen in Figure 3.5. Matured oocytes had either
one pronucleus, a metaphase two plate or were anaphase stage (detailed tables found in
Appendix C). Immature group indicated oocytes in metaphase one or germinal vesicles being
present, and polyspermy means polyspermy fertilization occurred. The degenerate variable
means that the oocytes were dead. The indeterminate variable means that the oocytes were
unknown, had sperm heads and/or cumulus cells interfering with visualization (Appendix C).

Table 3.4 Nuclear status of Mature Oocytes after IVF with DMSO (N=103) and Glycerol
(n=88)
DMSO % (no.)

Glycerol % (no.)

P value

Matured ᴬ

29.12% (30/103)

13.63% (12/88)

0.0136

Fertilized

12.62% (13/103)

3.41% (3/88)

0.0335

Immature

4.85% (5/103)

1.14% (1/88)

0.2201

Polyspermy

0% (0/103)

3.4% (3/88)

0.0960

Degenerate

45.63% (47/103)

56.82% (50/88)

0.1470

Indeterminate

20.39% (21/103)

25.00% (22/88)

0.4895

ᴬOocytes matured includes oocytes fertilized
*Proportions with a probability value of P<0.05 were considered significantly different
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Figure 3.5 Different stages of nuclear maturation of Mature DMSO (A) and Glycerol (B)
cryoprotectant treatments.

IVF VALIDATION RESULTS
To validate IVF procedure, in vitro fertilization procedure was done with matured
cumulus cell complexed bovine oocytes from a commercial source for the sole purpose of
validating IVF. 63.88% were fertilized (46/72). In conclusion our IVF methods could be utilized
to analyze the pronuclear formation with bovine cumulus cell complex oocytes.
MATURATION CHECK
Maturation rate was evaluated in a subset of oocytes from each group, in the first
experiment maturation was evaluated after IVM and vitrification. The first experiment,
immature oocytes showed that 2/10 oocytes advanced to metaphase two stage in the glycerol
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treatment group, 4 were lost or crushed and 4 were immature. Within in the DMSO treatment
group 3/10 showed metaphase one maturation, 2 exhibited germinal vesicles and 1 confirmed
germinal vesicle breakdown, and 3 were degenerate. Therefore 20% showed maturation prior
to IVF in the immature glycerol group and 30% showed maturation prior to IVF in the
immature DMSO group.
In experiment two after IVM and prior to vitrification 61.5% attained a metaphase two
plate indicating maturation. After vitrification and warming of matured oocytes in the second
experiment maturation in both cryoprotective groups was evaluated prior to IVF and 0%
showed a metaphase two plate, all were degenerate regardless of treatment.
DISCUSSION
The aim of these experiments was to determine if immature and mature cumulus cell
oocyte complexes cryopreserved via vitrification with dimethyl sulfoxide or glycerol solutions
would illustrate pronuclear formation following warming and in vitro fertilization, indicating
viability. Discovering an optimal vitrification, warming, IVF, and culture procedure for bovine
immature and mature cumulus cell complexes would be beneficial for infertility issues and
improving gene pools. Within these experiments we made some progress towards optimizing
the conditions of vitrification with bovine oocytes.
In the first experiment, fertilization occurred within the DMSO treatment group but not
the glycerol treatment group, however, there was statistically significant difference (P=0.0056)
between treatment groups, due to the proportions of oocytes in DMSO treatment group being
fertilized (Table 3.3). The low fertilization rates in the first experiment could be affected by the
maturation rate of the oocytes. After vitrification the oocytes most likely did not mature
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properly or were morphologically altered leading to the low fertilization rates (8.49% DMSO)
but the high number of oocytes that were still in the metaphase two stage (12.26% DMSO
2.47% glycerol) could indicate issues with the formation of metaphase plates after vitrification
and upon warming and IVM. These results showed a significant difference between DMSO and
glycerol (P=0.0149) suggesting that DMSO cryoprotectant is significantly superior for
cryopreservation followed by maturation of oocytes when combined with ethylene glycol.
Specifically, a possible interruption of the tubulin formation. The spindle apparatus is a
dynamic conglomerate of microtubules and associated structural proteins, acting to
coordinate cytokinetic and karyokinetic events essential for normal chromosome segregation
(Jung, 2014). First meiotic division is completed by cooperation of cytoskeletons, especially
microfilaments and microtubules. The cytoskeleton is a key factor to successful competent
oocytes. Matured oocytes stay in metaphase block until the entry of spermatozoa (Pickering,
1987). This block is accomplished by stable spindle and other regulators for cell cycle. As
oocytes transit into metaphase, microtubules change from radial arrays to an organized barrel
shaped structure containing dense material at either pole known as microtubules organizing
centers (MTOCs) (Aman, 1994). The polyspermic fertilization in the first experiment
(3.77%DMSO, 3.70% glycerol) may indicate a possibility that vitrification of oocytes is affecting
the zona pellucida’s ability to become hardened after fertilization possibly disrupting the
cortical granule reaction. The cortical reaction is a process initiated during fertilization by the
release of cortical granules from the oocyte which prevents polyspermic fertilization. In
contrast to the fast block of polyspermy which immediately but temporarily blocks additional
sperm from fertilizing the oocyte, the cortical reaction gradually establishes a permanent
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barrier. Another hypothesis is that the cryoprotectants are not penetrating the cell membrane
creating osmotic stress on the oocytes and ice crystals are forming. These ice crystals can
puncture holes through the cell membrane allowing multiple spermatozoa to enter the
oocytes cytoplasm and causing polyspermic fertilization. If the spermatozoa are not
penetrating the membrane and entering through possible holes formed by ice crystals then
oocyte activation is not occurring, producing multiple sperm pronuclei but not the maternal
pronucleus. Polyspermic fertilization of oocytes could also be affecting the intracellular
calcium concentration resulting in an elevation after cryopreservation, which could trigger
cortical granule release and cause premature hardening of the zona pellucida and
parthenogenetic activation. These results can be compared to the fact that our controls had no
sign of polyspermic fertilization. There was also a trend of degeneration in experiment one
that points to an influence of deleterious trends of vitrification and possibly from the
cryoprotectants used that effect the immature oocytes ability to become matured and/or
affect the oocytes that did become mature to become fertilized.
In the second experiment we saw a statistically significant difference between
treatments of DMSO and glycerol when looking at the fertilization rate after IVF, DMSO being
12.5% fertilized (13/103) and glycerol being 3.4% fertilized (3/88) with a P value of 0.0335
indicating a significant difference between the two cryoprotectants. These results indicate that
both combinations of cryoprotective agents in vitrification can be used successfully for both
mature bovine oocyte cumulus cell complexes but that DMSO cryoprotectant may be a more
suitable agent for matured bovine oocytes. A large portion of oocytes remained in the
metaphase two stage (29.12% DMSO 13.63% glycerol) with a P value of 0.0136 after IVF
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leading us to believe that vitrification is affecting the viability and altering the oocytes prior to
IVF. These results also suggest that DMSO cryoprotectant is more ideal for recovering the
metaphase plate of oocytes after cryopreservation. It has been well documented that oocytes
suffer from reversible and irreversible damage during cryopreservation. This damage includes
hardening of the zona pellucida, premature cortical granules release, depolymerization of the
microtubules, and misalignment of the chromosomes. Vitrification has in the past negatively
affected spindle morphology and other organelle morphology in mature oocytes (Purohit,
2012) and could possibly be affecting mature oocytes after vitrification in this experiment as
well. Importantly, the mechanism of meiotic spindle regeneration after oocyte
cryopreservation is essentially unknown (Ma, 2010) In Table 3.3 and Figure 3.5 there were
oocytes showing maturation after IVF indicating that spindle repair occurred but fertilization
could not, possibly be effecting the tubulin or pre-hardening of the zona pellucida. Studies
with mice demonstrated that cryopreservation induced hardening of the zona pellucida and
premature release of the cortical granule content (Al- Hasani, 1987, Gook, 1993) inhibiting
sperm penetration and fertilization. During the freezing process, fracture of the zona pellucida
and ooplasmic membrane disruption could also occur. In a past experiment taxol was used to
help re-polymerize disrupted microtubules of somatic cells (Jordan et al. 1993) and oocytes
(Morato et al. 2008) and is a cytoskeleton stabilizer. Taxol has been shown to improve
vitrification of human immature oocytes and bovine, ovine and murine mature oocytes (Shi et
al. 2006, Morato et al. 2008, and Zhang, 2009) Cytochalasin B is also a cytoskeletal stabilizer
and has also been suggested to improve post- thaw development of mouse and porcine
oocytes (Park, 2001, Dobrinsky, 2000). There was also a trend of degeneration in experiment
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two that points to an influence of deleterious trends of vitrification and possibly from the
cryoprotectants used that effect the mature oocytes ability to repair the metaphase spindles
or other organelle disruption or can affect the matured oocytes after vitrification to become
fertilized.
In both experiments during warming, the dilution solution consisted of PBS, calf serum,
and sucrose. Vitrified oocytes are sensitive to osmotic changes during warming. Many studies
have a warming procedure in a series of steps, starting at a high concentration of an
extracellular agent like sucrose and reduce it over a short period of time. In the book titled
Human Assisted Reproductive Technology, Gardner explains that warming human embryos
first go into a sucrose solution of 0.65M for 30seconds, then into 0.325M sucrose for 1 minute,
0.125M sucrose for 2 minutes then 0.0M sucrose for 5 minutes. The results yielded a 92.1%
cryosurvival rate (Gardner, 2011). As early as in 1993, mouse embryos were vitrified with
2.75 M dimethyl sulfoxide and 2.75 M propylene glycol supplemented with 1.0 M sucrose after
30 second exposure, which revealed a significantly higher in vitro survival rate of 82% than the
solution without 1.0 M sucrose, 44% (Tada, 1993). Additionally, it has been reported that
vitrification solution with sugars could improve the survival rate of the vitrified bovine
blastocysts (Saito, 1994). In another study the use of sucrose in the warming solutions had no
significant effect on expansion or hatching rates on vitrified mouse embryos, results yielded
76-82% with 0.0M sucrose compared to 40-54% with 0.8M sucrose. It was concluded that
vitrification solutions should contain a moderate concentrations of sucrose, however in
dilution medium sucrose is unnecessary (Al Yacoub, 2013). In the two experiments of this
thesis the warming solution consisted of 0.025M sucrose and oocytes were washed for 5
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minutes. Originally the protocol called for 0.5M sucrose for the vitrification solutions and the
dilution solution, however the warming solution contained a reduced amount of sucrose to
observe the cryosurvival of a lower concentration. In reported studies it has been
demonstrated that a high concentration of sucrose is not needed for warming solution after
vitrification and a lower amount has beneficial factors on cryosurvival (Al Yacoub, 2013). The
results in the present study had a low survival rate in both experiments indicating that there
could be a possibility of reduced cryosurvival with the vitrification process or the warming
process. This could be a possible future experiment, comparing a low sucrose concentration
with a higher sucrose level in the warming solution and in the vitrification solutions to see
possible morphology changes.
There were trends that focused our attention to the cryoprotectant DMSO showing
more promising results in fertilization rates in both experiments, 8.49% fertilization in DMSO
to 0% in glycerol and 12.62% in DMSO and 3.4% in glycerol in the second experiment. We
cannot say that there was a statically significant difference between the two experiments, but
what we observed we can say that dimethyl sulfoxide may have a better potential in
vitrification of both immature and mature bovine oocyte and bears further investigation.
Previous studies demonstrated the beneficial effect of DMSO in spindle polymerization
(Kuleshova, 1999). Therefore, the use of DMSO for oocyte cryopreservation might have a
protective effect during vitrification (Kuleshova, 1999, Katayama, 2003) These results provide
the opportunity to explore other variables with optimizing the vitrification procedure or
protocol for a particular cell type, or size. A good place to start would be assessing epigenetic
changes. In a recent study, acetylation of H4 and methylation of H3K9 were altered by
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vitrification that may lead to abnormal epigenetic presentation of female chromatin to
fertilization and may be responsible for the reduction of developmental competence of
vitrified pig oocytes (Spinaci, 2012). Both of these histone modifications could also be useful
markers to monitor epigenetic perturbations induced by various experimental vitrification
protocols and eventually for optimizing the cryopreservation of human oocytes (Yan, 2010).
During these two experiments, many obstacles occurred and trouble shooting was
necessary. During both experiments there were possible problems with different protocols
and media solutions. There are many protocols with different additives that contribute to the
growth and development of oocytes and embryos. The exploration for a perfect maturation
media for bovine oocytes alone could be an experiment and the search for the optimal culture
for bovine embryos could also be extensively explored, including in vitro fertilization
procedure. Amino acids, growth factors, different serum, a base buffer all could be altered and
produce different results.
In our isolate we found that it could be possibly causing DNA damage to sperm cells
due to contamination with ions during sperm separation. The production of nitric oxide, is
regarded as a sperm toxicant that reduces motility (Rosselli et. al, 1995). This could be due to
an activation of guanylyl cyclase, that increases cGMP production, which inhibits sperm
motility (Chan et. al, 1990). On the other hand, nitric oxide is also known to be a physiologic
mediator for vasodilatation, immunosuppression, neurotransmission and cytotoxicity (Anggard
et. al, 1994). This could cause poor fertility rates with the IVF protocol and embryo
development (Nathanet. al, 1992). One of the main factors known to influence quality and
fertility of bovine cryopreserved semen is the extender used. Despite the benefits of egg yolk
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on semen cryopreservation, components of animal origin may represent a potential
microbiological risk, compromising the quality of cryopreserved semen and standardization
(Bousseau et. al, 1998). The egg yolk extender within the freezing media during this
experiment could be resulting in complications in spermatozoa attaching and entering the
zona pellucida for fertilization. In a recent study, lecithin, can be used in substitution for egg
yolk as an extender (Forouzanfar et. al, 2010). We did see a significant difference between the
IVF validation experiment and both treatments in both experiments in regard to fertilization
despite using semen from the same bull. The quality of the sperm, extender and isolate used
could produce lower results but was not observed during the results.
Temperature sensitivity is always a problem that needs to be avoided during
cryopreservation and thawing of cells, but it also can be a problem during collection of the
bovine oocytes (Mortimer et. al, 2015). During collection the filter that holds the follicular fluid
and oocytes are washed in a warmed holding media but are at room temperature for the
collection period. The collection room is in doors and the rooms temperature is controlled.
This change in temperature from the ovary to the warm media to cooling within the filter then
back into warmed searching media could cause a problem with maturation and/or fertilization
or aneuploidy due to chilling factors. In regard to the IVF validation oocytes, they were also
collected but from a slaughter house. These procedures were done elsewhere so comparison
with temperature sensitivity cannot be fairly measured to one another. The problem of
maintaining temperature throughout the OPU and oocyte search procedure is an excellent
illustration that not only do perceived problems represent opportunities for improvement.
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There also is a possibility that the age of the cows can affect the quality of the collected
oocytes within each experiment and the opportunity to become viable embryos. In one study
results suggested that the fertilization ability of oocytes from older cows is low and that
premature progression of meiotic division in oocytes is partly due to impaired oocyte-CC gap
junction communication (Yamamoto et. al, 2010). Synchronizing the herd could have also
helped retrieve larger and better quality oocytes within the follicles. During synchronization
procedure the herd is reproductively synchronized to one another. This produces a new
follicular wave to be created and releases a new dominant follicle. The better quality the
oocytes the greater the chance they would become fertilized (Yamamoto, 2010). After
collection, the filter was searched for the oocytes and removed. During this experiment we
used no scale or judgment on collected oocytes quality. No morphology features were
evaluated to choose one oocyte over the other. Lonergan and colleagues demonstrated the
effect of follicle size on bovine oocyte quality and developmental competence following
maturation, fertilization and culture in vitro for porcine (Lonergan et. al, 2005) and concluded
that oocytes from >6mm follicles yielded better results (Lonergan et. al, 2005). All oocytes
collected were used in this experiment and this could have caused lower maturation rates and
lower fertilization rates.
Another option was to use a pre-IVM media. This may have increased the quality of
maturation rather than holding them within HEPES-TALP after collection of oocytes for both
experiments. Mitochondrial activity can be increased as well as the nuclear maturation and
developmental competence, the amount of ICM cells increase, and the percentage of embryo
development increases when using a pre-IVM culture (Huang et. al, 2014). In a recent study
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Pre-IVM with FSK + IBMX increased subsequent blastocyst formation rate and quality
compared with standard IVM (Li et. al, 2016). Pre-IVM could have been an advantage during
these experiments and may have improved our fertilization results.
Overall, fertilization rates were uniformly low across treatment groups. While this
could be due to the vitrification procedure, there are many other aspects that may have
contributed to low fertilization. Initially this study faced many obstacles, which were overcome
in a series of pre-trials to optimize the in vitro maturation and fertilization (as proven with our
IVF validation experiment). As such, we believe that our results further show that vitrification
still needs improvement to be efficient for bovine oocytes cryopreservation. However, results
indicate that the best course would be to focus on mature bovine oocyte vitrification.
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CHAPTER IV
SUMMARY AND CONCLUSION
SUMMARY
Oocyte cryopreservation is a reproductive technique that has been a useful tool for a
number of industries, including livestock production, human infertility treatment, endangered
species, preservation and stem cell research. Commercial and research industries depend on
producing viable and developmentally competent oocytes and embryos for optimal success. It
has been found that in vitro culture systems need to be improved to optimize oocyte and
embryo quality and pregnancy rates and allowing for the wide spread of genetic resources
(Rodriguez et. al, 2012) within cryopreservation. One example includes bovine zygotes
cultured in vitro are capable of rates of development similar to those of in vivo cultured
counterparts (in terms of day 8 blastocyst yield, cell number and early pregnancy rate), there
were significant differences in embryo cryosurvival. This suggests that current in vitro culture
systems need to be improved to optimize embryo quality and pregnancy rates (Enright et. al,
2000). It has been demonstrated that there is a dramatic effect on blastocyst quality with
those blastocysts produced following in vivo culture surviving vitrification at significantly
higher rates than in vitro cultured counterparts (Rizos et. al, 2002). Successful
cryopreservation of spermatozoa and embryos made assisted reproductive technologies more
practical and available for commercial use, because of the potential advantages to allow long
distance transportation and to avoid estrous synchronization. This reduces the size of the
recipient female population necessary to be maintained. Cryopreservation of oocytes has short
and less successful history when compared to the other reproductive cells such as
spermatozoa and embryos. Cryopreservation of unfertilized oocytes can be combined with
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these advanced reproductive technologies, in addition to its potential advantage as oocyte
banking for preserving female genetic resources. During maturation of an oocyte centromeres
attach to the spindle fibers from the centrosome at the opposite poles in metaphase II and will
not continue until fertilization occurs (Raven et. al, 2016). The most characterized cytoskeletal
damage by cryopreservation concerns the disruption of sub-cortical actin network,
microtubule depolymerization, abnormal spindle configuration and chromosome scattering
within mature oocytes and therefore compromising the ability to develop into a viable embryo
(Ferris et. al, 2015). Cryopreservation of germinal vesicle immature oocyte bypasses the risk of
chromosome abnormalities as the chromatin is decondensed and is still protected by the
nuclear envelope (Senger, 2005). However, cryopreservation of immature oocytes at the GV
stage is also the subject for challenging endeavor. In many studies it has been shown that
cryopreserving immature oocytes harms the ooplasm (Kim et. al, 2014), potentially due to
inadequate conditions of in vitro maturation or basic oocyte defects. To date, with current
protocols it may be best to cryopreserve mature oocytes after in vitro maturation to
metaphase II (Combelles et al. 2012). Cryopreserving after maturation to metaphase II still
leaves us with the issue of the spindle fibers being damaged during cryopreservation by ice
crystal formation.
Cryoprotectant is the functionally derived term created to describe any additive which
can be provided to cells before freezing to yield a higher post thaw survival and help reduce
the amount of ice crystals formed within the cell. Cryoprotectants also help to ensure high
levels of cell viability post thaw, and lower freezing temperatures allowing for greater
dehydration of cells before water freezes (Watson, 1995). The most common cryoprotectants
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used with embryos and oocyte cryopreservation are dimethyl sulfoxide and glycerol. Both of
these cryoprotective agents are comparable to one another in many respects. In recent studies
dimethyl sulfoxide has been used more often for oocytes and embryos (Schellander et. al,
1994). In one particular study dimethyl sulfoxide treatment led to significantly better cleavage
and development up to 4-cell stage in oocytes cryopreserved at the MII stage (Schellander et.
al, 1994). In another study it was found that when using glycerol and 1,2- propanediol in
vitrification of bovine blastocysts the success following the 16 step equilibration minimized the
ultrastructural damage to the plasma membrane during freezing and therefore ice crystal
formation (Kuwayama et. al, 1994). Depending on the source consulted, there have been
variable results on the relative toxicity of the different cryoprotectants, with disagreement on
which is the least or most toxic (Lawson and Sambanis, 2011). Many factors for optimizing
cryopreservation are dependent on the cell type and species including cryoprotectants used
experimental protocols and thawing time.
CONCLUSION
The results of the first experiment show a decrease in survival and development after
vitrification and IVF. Fertilization rate in the first experiment of 8.49% DMSO vs 0% glycerol,
were low and did have a significant difference between the two (p=0.0056) due to fertilization
in the DMSO group and not within the glycerol treatment group. The results showing
polyspermic fertilization in the first experiment (3.77%DMSO, 3.70% glycerol) may indicate a
possibility that vitrification of oocytes is affecting the zona pellucida ability to become
hardened after fertilization possibly disrupting the cortical granule reaction. Reiterating that
cryopreservation of immature oocyte still has a way to go in optimizing protocols with the
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majority degenerate after IVF (74.04% DMSO, 80.49% glycerol). In the second experiment we
did have some progress in optimizing the vitrification protocol for bovine mature oocytes with
the results showing DMSO having a significant difference in fertilization rate compared with
glycerol (P=0.0056). Results also demonstrated that DMSO did recover the metaphase plate
within the oocytes after vitrification at a higher rate than glycerol (29.12%, 13.63%, P value=
0.0136) Overall, the majority of oocytes were degenerate like in the first experiment (45.63%
DMSO, 56.82% glycerol) indicating vitrification and warming could be damaging oocytes.
Future research is needed on the varying levels of cryopreservation via vitrification of
immature and mature bovine oocytes. Specifically, on mature oocytes, while they
demonstrated higher survival and fertilization rates in both treatment groups. For example,
allowing vitrified mature oocytes to repair the spindles for a limited time after warming may
allow for higher fertilization rates after IVF or the additional of calcium. DMSO induced calcium
increases solely from the internal calcium pool was found that zona hardening significantly
reduces and subsequent fertilization and development to the two cell stage significantly
increased (Larman, 2006). Since zona hardening is one of the early activation events normally
triggered by the sperm induced calcium increases observed at fertilization, it is possible that
other processes are negatively affected by the calcium rise caused by cryoprotectants used
during oocyte freezing, which might explain the current poor efficiency of this technique.
There are still many aspects of oocyte cryopreservation that are not fully understood
yet. Cryoprotectants are just one small factor in the big picture that involves many other
pathways. Further research into the understanding of details of oocyte cryopreservation is
necessary. This may help understand different protocols or factors influencing
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cryopreservation and warming to increase the overall development and competence of oocyte
survival and fertilization of vitrified oocytes.
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APPENDIX A
PROTOCOLS

Vitrification for Bovine Oocytes
1. Prepare equilibration and vitrification solutions before beginning (Appendix B).
2. Place 3-5 oocytes in equilibration solution (solution one) 50uL drop for 5 minutes,
pipette oocytes up, down and around dish for continued time during 5 minute interval.
3. After 5 minutes in first solution move oocytes to second solution (50uL drop) for 35-40
seconds, pipetting them around the dish.
4. In the last 15 seconds of a total of 45 seconds in the second solution, pipette oocytes
up and down and place on cryolock with minimal media.
5. After oocytes are placed on the tip of the cryolock and media removed, plunge cryolock
into liquid nitrogen and repeat until all oocytes are vitrified.
6. With forceps, gently secure the top onto the cryolcok device under the liquid nitrogen.
7. Move all cryolock with tops into canister for storage.
In Vitro Fertilization for Bovine Oocytes
Preparation:

1. Place two centrifuge carriers into non CO2 incubator (39°C).
2. Prepare IVF-TALP. Check that there is warmed mineral oil in a CO2 incubator.
3. Prepare 500µl of IVF-TALP in four well dish with water surrounding each well. Prepare
enough drops for the number of oocytes to be fertilized using 1 well per 15-20 oocytes.
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Add 500 ul IVF-TALP in each well of a four well plate for use for washing. Equilibrate in
CO2 incubator for at least 2-3 hours.
4. Place tube with remaining IVF-TALP into the CO2 incubator (loosened cap).
5. Prepare Percoll (Isolate) gradient. Place 1.5 ml 90% lower layer in 15 ml centrifuge
tube. Carefully add 1.5 ml of 45% upper layer on top in a manner that does not cause
mixing of the two layers.
6. Transfer gradient to a pre-warmed centrifuge carrier in the non CO2 incubator.
7. Add 95 ul water to a small centrifuge tube or use later with sperm counting (keep at
room temperature).
8. Wash hemacytometer and cover slip with alcohol and place on microscope.
9. Clean microscope slides and coverslips and place on warming plate to use for checking
motility later. Place a microcentrifuge tube on warming plate to use for the sperm
pellet later.

Semen Thaw and Preparation of Sperm Suspension:

1. Thaw semen in water bath at 39°C for 30 seconds being careful not to raise remaining
straws in LN tank above the frost line.
2. Dry straw and keep it warm. Cut the sealed end off and, using a plunger carefully layer
the semen on top of the percoll gradient in a manner that does not cause mixing.
3. Check for motility of the thawed semen by placing a drop remaining in the straw on the
pre-warmed slide. View at 20X or 40X magnification to confirm motility. If motility is
not present prepare a new gradient and thaw another unit of semen.
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4. Return the gradient with semen to the pre-warmed centrifuge carrier and centrifuge at
400 xg for 20 minutes at 37°C.
5. While the sperm is in the centrifuge, use this time to move the oocytes from
maturation medium into IVF-TALP. Wash oocytes through the IVF-TALP using the
prepared wash dish from the CO2 incubator.
6. Transfer 15-20 oocytes to each 500 ul drop of IVF-TALP in the fertilization dish and
return fertilization dish to the CO2 incubator.
7. With 2 minutes remaining on the centrifuge time, place 3 ml of IVF-TALP in a 15 ml
centrifuge tube and return to CO2 incubator.
8. When centrifugation is complete carefully remove carrier with gradient from the
centrifuge. There should be a sperm pellet in the bottom of the tube. If not start over.
9. With a 5 ml pipet, remove the extender (top layer) and the dead sperm (at the
interphase).
10. Collect 200 ul of sperm pellet from the bottom of the centrifuge tube and add slowly to
the 3 ml of IVF-TALP.
11. Centrifuge 400 xg for 10 minutes. During this time add 2 ml of IVF-TALP to a new 15 ml
centrifuge tube and return to the CO2 incubator.
12. When centrifugation is complete remove ~ 3 ml of the medium from the top of the
tube.
13. Collect 200 ul of sperm pellet from the bottom of the centrifuge tube and add slowly to
the 2 ml of IVF-TALP.
14. Centrifuge 400 xg for 5 minutes.
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15. Remove ~ 1 ml of medium from the top of the tube.
16. With a 200 ul pipettor collect the pellet at the bottom of the tube. Collect no more
than the pellet and place in the pre-warmed sperm pellet tube. Keep this tube on the
warming plate until ready for fertilization.
17. Determine the sperm pellet concentration:

a. Gently mix the sperm pellet and transfer 5 ul into the 95 ul water prepared earlier
(1:20 dilution).

b. load each side of the hemacytometer with 10 ul of the diluted sperm. Count the
sperm heads within five double-ruled squares on each side of the hemacytometer.
These two counts should not vary more than 10%. If they do clean the
hemacytometer, reload and count again.

18. Prepare the final sperm suspension:

a. Average the two counts from above. This number (x) will be divided into 7500 to
determine the µL of sperm pellet required to prepare the final suspension. Subtract this
number from 300 to obtain the µL of IVF-TALP for the suspension.

Eg: 7500/x = __µl sperm pellet ; 300 – __µ of sperm pellet = __µl of IVF-TALP.

b. Add the calculated amount of IVF-TALP to the pre-warmed micro centrifuge tube
and then add the calculated amount of sperm pellet. The final sperm suspension will
be 300 µl. Mix gently by pipetting.
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Fertilization:

1. To each fertilization drop with oocytes add 20 µl of Heparin stock.
2. To each fertilization drop with oocytes add 20 µl of Penicillamine/Hypotarine (PH)
stock.
3. To each fertilization drop with oocytes add 20 µl of final sperm suspension for a final
concentration of 1 x 106 sperm/ml in the fertilization drops.
4. These last three steps should be done rapidly and the fertilization dishes returned to
the CO2 incubator as rapidly as possible.

Culture:

1. Prepare culture dishes with 40uL droplets of global 35+ covered with mineral oil and
wash droplets and place into 5% CO2 incubator at least 2 hours prior for equilibration.
2. After 18 hours within 5% CO2 incubator, remove oocytes and place into 1mL centrifuge
tube of hyaluronidase and vortex for 5-7 minutes to remove cumulus cells.
3. When all cumulus cells removed, wash presumptive embryos in culture droplets and
then transfer into fresh droplets for an additional 24 hours in 5% CO2 incubator.

Aceto-Orcein Staining Protocol for Oocytes or Embryos
1. Prepare aceto-orcein stain and methanol/acetic acid solution before beginning
(Appendix B).
2. Use a pencil to label the top of a microscope slide with the date, number of
oocytes/embryos to be mounted, and any other relevant information.
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3. Place small paraffin wax/vaseline posts onto each of the four sides of the coverslip.
Place ≈10 oocytes/embryos onto the microscope slide, making sure none are on top of
each other. Draw off excess medium as possible to ensure that they stick to the slide.
4. Quickly place the coverslip onto the slide to prevent dehydration.
5. While viewing the oocytes/embryos under the stereoscope, use a small stick or
pencil to apply gentle pressure on each side of the coverslip at the posts. The
oocytes/embryos should become slightly flattened to secure them in place but not
mashed enough to break the zona. An air bubble will form around the oocyte when
secured to the slide.
5. Place rubber cement on two corners of the cover slip.
6. Tilt the coplin jar containing methanol/acetic acid fixative, and gently submerse the
slide into the solution. The rubber cement glue will harden on contact with the fixative.
7. Stain and view after at least 48 hours of fixing. Slides can safely be stored in the coplin
jars for up to 7 days.
Staining:
a. View between 48 hours and 7 days after mounting.
b. Place one drop of aceto-orcein stain on one open side of the coverslip.
c. Draw stain across the slide by placing a Kim wipe on the side of the coverslip
opposite the drop of stain. An extra drop of stain can be placed on the slide to prevent
the preparation from drying during viewing.
d. Use microscope to view oocytes/embryos. Record observations and take
photographs if necessary.
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Hoechst 33342 Staining Protocol for Oocytes or Embryos
1. Prepare Hoechst 33342 stain solution before beginning (Appendix B).
2. Wash presumptive embryos 1x in PBS.
3. Incubate for 30 minutes in 10 µL/ mL Hoechst 33342 in a 5% CO2 incubator at 37ᵒC.
4. Rinse in Dulbecco’s Phosphate-Buffered Saline.
5. Use a pencil to label the top of a microscope slide with the date, number of embryos
to be mounted, and any other relevant information.
6. Transfer presumptive embryos in a minimal amount of media, 8-10 embryos per
slide.
7. Add a 10 µL drop of Molecular Probes Prolong Gold Antifade (P36930) on top of
presumptive embryos and gently place coverslip on top.
8. Use microscope to view embryos. Record observations and take photographs if
necessary.
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APPENDIX B
MEDIA FORMULATIONS AND STOCK SOLUTIONS

Media Formulations:
HEPES-TALP Medium
pH should be 7.4. Sterile filter. Date, label and store at 4ᵒC for no more than one week.
Component
BSA, Fraction V
HEPES-TL
Na Pyruvate
Pen/Strep

Source
Sigma
Caisson
Stock solution
Gibco

Product Number
A-4503
IVL01
P-4562
15140

Amount
60 mg
20 mL
200 uL
200 uL

Maturation Media
Component
Medium-199
Fetal Bovine Serum
Pen/Strep
Na Pyruvate
Glutamine
FSH (Folltropin)

Source
Sigma
Cellgro
Gibco
Stock solution
100x stock solution
1000x stock solution

Product Number
M-4530
35-010-CV
15140
P-4562
G-8540
Bioniche

Amount
8.68 mL
1 mL
100 uL
100 uL
100 uL
10 uL

Sterile filter. Date, label, and store at 4ᵒC for up to one week.

IVF-TALP Medium
Component
TL-FERT
PH
1Heparin
Pen/Strep
Na Pyruvate
BSA

Source
Caisson
Stock solution
Stock solution
Gibco
Stock solution
Sigma

Product Number
IVL02
P-4875 / H-1384
H-3149
15140
P-4562
A-6003

Sterile, filter. Date, label and store at 4ᵒC for up to one week.
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Amount
22.5 mL
1 mL
1 mL
250 uL
250 uL
150 mg

Vitrification Solution One for Glycerol
PBS
20% Calf Serum
10% Ethylene Glycol
10% Glycerol
0.5 M Sucrose

Vitrification Solution Two for Glycerol

3 mL
1.0 mL
0.5 mL
0.5 mL
0.855g

PBS
20% Calf Serum
20% Ethylene Glycol
20% Glycerol
0.5 M Sucrose

2 mL
1.0 mL
1.0 mL
1.0 mL
0.855g

Sterile, filter. Date, label and store at 4ᵒC for up to one week.

Vitrification Solution One for DMSO
PBS
20% Calf Serum
10% Ethylene Glycol
10% DMSO
0.5 M Sucrose

Vitrification Solution Two for DMSO

3 mL
1.0 mL
0.5 mL
0.5 mL
0.855g

PBS
20% Calf Serum
20% Ethylene Glycol
20% DMSO
0.5 M Sucrose

Sterile, filter. Date, label and store at 4ᵒC for up to one week.

Dilution Solution for Warming
PBS
20% Calf Serum
0.025 M Sucrose

16 mL
4 mL
0.855g

Sterile, filter. Date, label and store at 4ᵒC for up to one week.
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2 mL
1.0 mL
1.0 mL
1.0 mL
0.855g

Stock Solutions:
1. Dulbecco’s Phosphate-Buffered Saline: Add 100 mL of 10X D-PBS solution (Sigma D-1283) to
900 mL of autoclaved DI water to make 1 L of D-PBS. Store at room temperature. Add 10 mL of
Bovine Calf Serum (HyClone) and 1 mL of Heparin (Sagent Pharmaceuticals, Schaumburg, IL,
USA) to make the D-PBS oocyte collection medium.
2. Pen/Strep: Gibco 15140. Aliquot ≈500 μL of new pen/strep solution into sterile centrifuge
tubes. Store at -20°C until use.
3. Na Pyruvate: Sigma P-4562. Dissolve 22 mg of sodium pyruvate in 10 mL of sterile MilliporeQ water. Sterile filter into an aluminum foil-wrapped 15 mL conical tube and store at 4°C for up
to a month.
4. L-Glutamine: Sigma G-8540. Make a 100X stock solution with a concentration of 200 mM by
dissolving 2.92 g of glutamine in 100 mL of DI water. Aliquot 1.0 mL into sterile centrifuge tubes
and store at -20°C.
5. FSH: Folltropin-V (Bioniche). Make a 1000X stock solution (5 mg/mL) by diluting a 400 mg vial
of folltropin in 80 mL of DI water. Store at -20°C in 100 μL aliquots.
6. Hyaluronidase: Sigma H-3506. Prepare a 1 mg/mL solution by dissolving 10 mg hyaluronidase
into 10 mL of HEPES-TALP (see media formulations above). Aliquot 1 mL into 1.5 mL sterile
centrifuge tubes. Store at -80°C indefinitely.
7. Methanol/Acetic Acid Fixative: For use with aceto-orcein staining protocol, make a 3:1
methanol/acetic acid solution by adding 300 mL of methanol (Sigma M-1775) and 100 mL of
acetic acid (Sigma A-6283). Store at room temperature.
8. Aceto-Orcein stain: Prepare a 1% orcein stain by adding 100 mg of orcein (Sigma O-7380) to
10 mL of solvent consisting of 60% DI water, 40% acetic acid (Sigma A-6283).
9. Hoechst 33342: Dissolve 25 mg of Hoechst in 25 mL distilled water in a 50 mL centrifuge
tube. Aliquot in 1 mL microcentrifuge tubes (1 mL / tube). Store at -20ᵒC for several months. For
working solution in embryo culture or holding media dilute to 1 µg/mL.
10.Heparin: Dissolve H-3149 1 mg Heparin into 20 mL of 0.9% saline and filter. Store -20°C
11. PH: Combine 5 mL of 1 mM of Hypotourine and 5 mL of 2 mM Penicillamine to 8 mL of 0.9%
saline. Aliquot into 100 µL, store at -20°C.

87

APPENDIX C
DETAILED OOCYTE ASSESSMENT BREAKDOWN

Nuclear Maturation Breakdown of Oocytes/Embryos in Experiment One
Pronucleus
Two Pronuclei
Metaphase One
Metaphase Two
Anaphase
Polyspermy
Degenerate
Sperm and CC

DMSO % (no.)
3.23%(6/104)
2.15%(4/104)
0%(0/104)
1.8%(2/104)
0.54%(1-104)
2.15%(4-104)
41.40%(77/104)
6.45%(12/104)

Glycerol % (no.)
0%(0/82)
0%(0/82)
0.54%(1/82)
1.08%(2/82)
0%(0/82)
3.23%(6/82)
35.48%(6/82)
3.23%(6/82)

P value
0.0352
0.1315
0.4409
1.00
1.00
0.3402
0.3814
0.4551

Comparison of Nuclear Maturation in Exp. One, Immature Group with DMSO and Glycerol
* Proportion with a probability value of P< 0.05 were considered significantly different

Oocytes were analyzed in the following tables for nuclear status and development
following fertilization. For experiment one, the indication of fertilization included formation of
two pronuclei. Matured oocytes had either one pronucleus, a metaphase two plate or were
anaphase stage. Immature group indicated oocytes in metaphase one, and polyspermy means
polyspermy fertilization occurred. The degenerate variable means that the oocytes were dead.
The indeterminate variable means that the oocytes were unknown, had sperm heads and/or
cumulus cells interfering with visualization.
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Nuclear Maturation Breakdown of Oocytes/Embryos in Experiment Two
Pronucleus
Two Pronuclei
Metaphase One
Metaphase Two
Anaphase
Polyspermy
Degenerate
Sperm and CC
Germinal Vesicle
Three Cell
Four Cell

DMSO % (no.)
4.71%(9/103)
4.19%(8/103)
0.52%(1/103)
4.19%(8/103)
0%(0/103)
0%(0/103)
24.61%(47/103)
10.99%(21/103)
2.09%(4/103)
1.56%(3/103)
1.05%(2/103)

Glycerol % (no.)
2.62%(5/88)
1.57%(3/88)
0%(0/88)
1.57%(3/88)
0.52%(1/88)
1.57%(3/88)
26.18%(50/88)
11.52%(22/88)
0.52%(1/88)
0%(0/88)
0%(0/88)

P value
0.5794
0.2292
1.00
0.2292
0.4607
0.0960
0.1470
0.4895
0.3762
0.2501
0.5005

Comparison of Nuclear Maturation in Exp. Two, Mature Group with DMSO and Glycerol
* Proportion with a probability value of P< 0.05 were considered significantly different
Within the second experiment the categorization of oocyte development followed as
fertilization included formation of two pronuclei, three cell and four cell embryo development.
Matured oocytes had either one pronucleus, a metaphase two plate or were anaphase stage.
Immature group indicated oocytes in metaphase one and germinal vesicles being present, and
polyspermy means polyspermy fertilization occurred. The degenerate variable means that the
oocytes were dead. The indeterminate variable means that the oocytes were unknown, had
sperm heads and/or cumulus cells interfering with visualization.
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Nuclear Maturation Breakdown of Oocytes by Replicate (Day) in Experiment One

1pronuclei
2pronuclei
Met1
Met 2
Anaphase
Polyspermy
Deg/unknown
CC/Sperm

5-NOV
DM
Glycer
SO
ol
(no.
(no.)
)
0
0
0
0
0
0
0
0
0
0
3
6
2
4
12
6

6-Nov
DMS
Glycer
O
ol
(no.)
(no.)
0
3
0
2
1
0
14
0

0
0
1
2
0
0
10
0

12-Nov
DMS
Glycer
O
ol
(no.)
(no.)
5
1
0
0
0
1
35
0

24-Nov
DMS
Glycer
O
ol
(no.)
(no.)

0
0
0
0
0
0
33
0

1
0
0
0
0
0
27
0

0
0
0
0
0
0
19
0

Comparison of Nuclear Maturation in Exp. One, Immature Group with DMSO and Glycerol
seperated by each replicate in numbers D(DMSO=104) G(Glycerol=82)
Met=Metaphase, Deg=Degenerate, CC=Cumulus Cell

Nuclear Maturation Breakdown of Oocytes by Replicate (Day) in Experiment Two

1pronuclei
2pronuclei
3 Cell
4 Cell
Met 1
Met 2
Anaphase
Polyspermy
Deg/unknown
CC/Sperm
GV

4-Nov(no.)
D
G
4
2
0
0
1
0
1
0
0
0
4
3
0
1
0
3
13
7
0
3
3
0

28-Oct(no.)
D
G
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
17
0
0
1
1

8-Dec(no.)
D
G
1
1
1
1
0
0
1
0
0
0
1
0
0
0
0
0
7
10
8
8
0
0

10-Dec(no.)
D
G
1
1
3
0
0
0
0
0
1
0
3
0
0
0
0
0
4
11
12
7
0
0

15-Dec(no.)
D
G
3
1
4
2
1
0
0
0
0
0
0
0
0
0
0
0
4
5
1
4
1
0

Comparison of Nuclear Maturation in Exp. Two, Mature Group with DMSO and Glycerol
seperated by each replicate in numbers D(DMSO=103), G(Glycerol=88)
Met=Metaphase, Deg=Degenerate, CC=Cumulus Cell GV=Germinal Vesicle
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